10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

☒    QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2020

or

☐    TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ___ to ___

Commission File Number: 001-37527

XCEL BRANDS, INC.

(Exact name of registrant as specified in its charter)

Delaware	76-0307819
(State or Other Jurisdiction of	(I.R.S. Employer
Incorporation or Organization)	Identification No.)

1333 Broadway, 10th Floor, New York, NY 10018

(Address of Principal Executive Offices)

(347) 727-2474

(Issuer’s Telephone Number, Including Area Code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol	Name of each exchange on which registered
Common Stock, $0.001 par value per share	XELB	NASDAQ Global Market

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes   ☒      No   ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes   ☒    No   ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer ☐	Accelerated filer ☐
Non-accelerated filer ☒	Smaller reporting company   ☒
	Emerging growth company   ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   ☐

Indicate by a check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes   ☐    No   ☒

As of August 7, 2020, there were 19,231,040 shares of common stock, $.001 par value per share, of the issuer outstanding.

XCEL BRANDS, INC.

INDEX

	a
		Page
PART I - FINANCIAL INFORMATION		3
Item 1.	Financial Statements	3
	Unaudited Condensed Consolidated Balance Sheets	3
	Unaudited Condensed Consolidated Statements of Operations	4
	Unaudited Condensed Consolidated Statements of Stockholders’ Equity	5
	Unaudited Condensed Consolidated Statements of Cash Flows	6
	Notes to Unaudited Condensed Consolidated Financial Statements	7
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	23
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	33
Item 4.	Controls and Procedures	33
PART II - OTHER INFORMATION		34
Item 1.	Legal Proceedings	34
Item 1A.	Risk Factors	34
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	36
Item 3.	Defaults Upon Senior Securities	36
Item 4.	Mine Safety Disclosures	36
Item 5.	Other Information	36
Item 6.	Exhibits	36
	Signatures	37

2

PART 1. FINANCIAL INFORMATION

ITEM 1.    FINANCIAL STATEMENTS

Xcel Brands, Inc. and Subsidiaries

Unaudited Condensed Consolidated Balance Sheets

(in thousands, except share and per share data)

	June 30, 2020		December 31, 2019
	(Unaudited)		(Note 1)
Assets
Current Assets:
Cash and cash equivalents	$	5,461	$	4,641
Accounts receivable, net		6,543		10,622
Inventory		866		899
Prepaid expenses and other current assets		1,775		1,404
Total current assets		14,645		17,566
Property and equipment, net		3,866		3,666
Operating lease right-of-use assets		8,569		9,250
Trademarks and other intangibles, net		108,815		111,095
Restricted cash		1,109		1,109
Other assets		494		505
Total non-current assets		122,853		125,625
Total Assets	$	137,498	$	143,191
Liabilities and Equity
Current Liabilities:
Accounts payable, accrued expenses and other current liabilities	$	2,722	$	4,391
Accrued payroll		527		1,444
Current portion of operating lease obligation		1,873		1,752
Current portion of long-term debt		2,900		2,250
Total current liabilities		8,022		9,837
Long-Term Liabilities:
Long-term portion of operating lease obligation		8,789		9,773
Long-term debt, less current portion		15,231		16,571
Contingent obligation		900		900
Deferred tax liabilities, net		7,310		7,434
Other long-term liabilities		224		224
Total long-term liabilities		32,454		34,902
Total Liabilities		40,476		44,739
Commitments and Contingencies
Equity:
Preferred stock, $.001 par value, 1,000,000 shares authorized, none issued and outstanding		—		—
Common stock, $.001 par value, 50,000,000 shares authorized, and 19,231,040 and 18,866,417 shares issued and outstanding at June 30, 2020 and December 31, 2019, respectively		19		19
Paid-in capital		102,180		101,736
Accumulated deficit		(5,764)		(3,659)
Total Xcel Brands, Inc. stockholders' equity		96,435		98,096
Noncontrolling interest		587		356
Total Equity		97,022		98,452
Total Liabilities and Equity	$	137,498	$	143,191

See Notes to Unaudited Condensed Consolidated Financial Statements.

3

Xcel Brands, Inc. and Subsidiaries

Unaudited Condensed Consolidated Statements of Operations

(in thousands, except share and per share data)

	For the Three Months Ended				For the Six Months Ended
	June 30,				June 30,
	2020		2019		2020		2019
Revenues
Net licensing revenue	$	4,501	$	6,803	$	10,142	$	14,666
Net sales		549		2,335		4,435		4,773
Net revenue		5,050		9,138		14,577		19,439
Cost of goods sold (sales)		253		1,767		2,653		3,599
Gross profit		4,797		7,371		11,924		15,840
Operating costs and expenses
Salaries, benefits and employment taxes		2,882		3,848		6,830		7,993
Other design and marketing costs		638		797		1,630		1,555
Other selling, general and administrative expenses		1,627		1,173		3,364		2,763
Stock-based compensation		488		135		731		482
Depreciation and amortization		1,329		1,000		2,632		1,948
Government assistance - Paycheck Protection Program		(1,640)		—		(1,640)		—
Property and equipment impairment		82		—		82		—
Total operating costs and expenses		5,406		6,953		13,629		14,741
Other income
Gain on reduction of contingent obligation		—		2,850		—		2,850
Total other income		—		2,850		—		2,850
Operating (loss) income		(609)		3,268		(1,705)		3,949
Interest and finance expense
Interest expense and other finance charges		299		348		593		638
Loss on extinguishment of debt		—		—		—		189
Total interest and finance expense		299		348		593		827
(Loss) income before income taxes		(908)		2,920		(2,298)		3,122
Income tax provision (benefit)		428		1,068		(124)		1,143
Net (loss) income		(1,336)		1,852		(2,174)		1,979
Less: Net loss attributable to noncontrolling interest		(36)		—		(69)		—
Net (loss) income attributable to Xcel Brands, Inc. stockholders	$	(1,300)	$	1,852	$	(2,105)	$	1,979
(Loss) earnings per share attributable to Xcel Brands, Inc. common stockholders:
Basic net (loss) income per share:	$	(0.07)	$	0.10	$	(0.11)	$	0.11
Diluted net (loss) income per share:	$	(0.07)	$	0.10	$	(0.11)	$	0.11
Weighted average number of common shares outstanding:
Basic weighted average common shares outstanding		19,132,244		18,976,394		19,001,321		18,770,378
Diluted weighted average common shares outstanding		19,132,244		18,977,051		19,001,321		18,771,053

See Notes to Unaudited Condensed Consolidated Financial Statements.

4

Xcel Brands, Inc. and Subsidiaries

Unaudited Condensed Consolidated Statements of Stockholders’ Equity

(in thousands, except share data)

	Xcel Brands, Inc. Stockholders
						Retained
	Common Stock					Earnings
	Number of			Paid-In		(Accumulated		Noncontrolling		Total
	Shares	Amount		Capital		Deficit)		Interest		Equity
Balance as of December 31, 2018	18,138,616	$	18	$	100,097	$	(233)	$	—	$	99,882
Issuance of common stock in connection with the acquisition of Halston Heritage	777,778		1		1,057		—		—		1,058
Compensation expense in connection with stock options and restricted stock	—		—		347		—		—		347
Net income	—		—		—		127		—		127
Balance as of March 31, 2019	18,916,394		19		101,501		(106)		—		101,414
Compensation expense in connection with stock options and restricted stock	—		—		135		—		—		135
Shares issued to employees in connection with restricted stock grants	60,000		—		—		—		—		—
Net income	—		—		—		1,852		—		1,852
Balance as of June 30, 2019	18,976,394	$	19	$	101,636	$	1,746	$	—	$	103,401
Balance as of December 31, 2019	18,866,417	$	19	$	101,736	$	(3,659)	$	356	$	98,452
Compensation expense in connection with stock options and restricted stock	—		—		91		—		—		91
Shares issued to executive in connection with stock grants for bonus payments	336,700		—		220		—		—		220
Shares repurchased from executive in exchange for withholding taxes	(155,556)		—		(102)		—		—		(102)
Net loss	—		—		—		(805)		(33)		(838)
Balance as of March 31, 2020	19,047,561		19		101,945		(4,464)		323		97,823
Compensation expense in connection with stock options and restricted stock	—		—		55		—		—		55
Shares issued to employees in connection with stock grants	270,728		—		265		—		—		265
Shares repurchased from employees in exchange for withholding taxes	(87,249)		—		(85)		—		—		(85)
Additional investment in Longaberger Licensing, LLC by non-controlling interest holder	—		—		—		—		300		300
Net loss	—		—		—		(1,300)		(36)		(1,336)
Balance as of June 30, 2020	19,231,040	$	19	$	102,180	$	(5,764)	$	587	$	97,022

See Notes to Unaudited Condensed Consolidated Financial Statements.

5

Xcel Brands, Inc. and Subsidiaries

Unaudited Condensed Consolidated Statements of Cash Flows

(in thousands)

	For the Six Months Ended June 30,
	2020		2019
Cash flows from operating activities
Net (loss) income	$	(2,174)	$	1,979
Adjustments to reconcile net (loss) income to net cash provided by operating activities:
Depreciation and amortization expense		2,632		1,948
Property and equipment impairment		82		—
Amortization of deferred finance costs		50		79
Stock-based compensation		731		482
Amortization of note discount		—		16
Allowance for doubtful accounts		683		(144)
Loss on extinguishment of debt		—		189
Deferred income tax (benefit) provision		(124)		1,143
Gain on reduction of contingent obligation		—		(2,850)
Changes in operating assets and liabilities:
Accounts receivable		3,396		2,289
Inventory		33		1,113
Prepaid expenses and other assets		(59)		(293)
Accounts payable, accrued expenses and other current liabilities		(2,688)		(3,532)
Cash paid in excess of rent expense		(181)		(244)
Other liabilities		—		(196)
Net cash provided by operating activities		2,381		1,979
Cash flows from investing activities
Cash consideration for acquisition of Halston Heritage assets		—		(8,830)
Purchase of property and equipment		(634)		(557)
Net cash used in investing activities		(634)		(9,387)
Cash flows from financing activities
Shares repurchased including vested restricted stock in exchange for withholding taxes		(187)		—
Payment of deferred finance costs		—		(289)
Proceeds from long-term debt		10		7,500
Payment of long-term debt		(750)		(2,742)
Net cash (used in) provided by financing activities		(927)		4,469
Net increase (decrease) in cash, cash equivalents, and restricted cash		820		(2,939)
Cash, cash equivalents, and restricted cash at beginning of period		5,750		10,319
Cash, cash equivalents, and restricted cash at end of period	$	6,570	$	7,380
Reconciliation to amounts on consolidated balance sheets:
Cash and cash equivalents	$	5,461	$	6,271
Restricted cash		1,109		1,109
Total cash, cash equivalents, and restricted cash	$	6,570	$	7,380
Supplemental disclosure of non-cash activities:
Operating lease right-of-use asset	$	—	$	10,409
Operating lease obligation	$	—	$	13,210
Accrued rent offset to operating lease right-of-use assets	$	—	$	2,801
Settlement of seller note through offset to receivable	$	—	$	600
Settlement of contingent obligation through offset to note receivable	$	—	$	100
Issuance of common stock in connection with Halston Heritage assets acquisition	$	—	$	1,058
Contingent obligation related to acquisition of Halston Heritage assets at fair value	$	—	$	900
Liability for equity-based bonuses	$	100	$	—
Amount due from non-controlling interest for capital contribution	$	300	$	—
Supplemental disclosure of cash flow information:
Cash paid during the period for income taxes	$	47	$	18
Cash paid during the period for interest	$	811	$	784

See Notes to Unaudited Condensed Consolidated Financial Statements.

6

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Unaudited Condensed Consolidated Financial Statements

June 30, 2020

(Unaudited)

1. Nature of Operations, Background, and Basis of Presentation

The accompanying condensed consolidated balance sheet as of December 31, 2019 (which has been derived from audited financial statements) and the unaudited interim condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial information and pursuant to the instructions to Form 10-Q and Article 8 of Regulation S-X promulgated by the United States Securities and Exchange Commission (“SEC”). Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a comprehensive presentation of financial position, results of operations, or cash flows.

In the opinion of management, the accompanying unaudited condensed consolidated financial statements were prepared following the same policies and procedures used in the preparation of the audited consolidated financial statements and reflect all adjustments (consisting of normal recurring adjustments) necessary to present fairly the results of operations, financial position, and cash flows of Xcel Brands, Inc. and its subsidiaries (the “Company” or "Xcel"). The results of operations for the interim periods presented herein are not necessarily indicative of the results for the entire fiscal year or for any future interim periods. These unaudited condensed consolidated financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K for the year ended December 31, 2019, as filed with the SEC on April 14, 2020.

The Company is a media and consumer products company engaged in the design, production, marketing, wholesale distribution, and direct-to-consumer sales of branded apparel, footwear, accessories, jewelry, home goods and other consumer products, and the acquisition of dynamic consumer lifestyle brands. The Company has developed a design, production, and supply chain capability driven by its proprietary integrated technology platform. Currently, the Company’s brand portfolio consists of the Isaac Mizrahi brands (the "Isaac Mizrahi Brand"), the Judith Ripka brands (the "Ripka Brand"), the Halston brands (the "Halston Brands"), the C Wonder brands (the "C Wonder Brand"), and other proprietary brands. The Company also manages the Longaberger brand (“the Longaberger Brand”) through its 50% ownership interest in Longaberger Licensing, LLC. The Company designs, produces, markets, and distributes products, and in certain cases, licenses its brands to third parties, and generates licensing fees. The Company and its licensees distribute through a ubiquitous-channel retail sales strategy, which includes distribution through interactive television, the internet, and traditional brick-and-mortar retail channels.

Recently Adopted Accounting Pronouncements

The Company adopted Accounting Standards Update ("ASU") No. 2018‑13, “Fair Value Measurement (Topic 820): Disclosure Framework – Changes to the Disclosure Requirements for Fair Value Measurement,” effective January 1, 2020. This ASU adds, modifies, and removes several disclosure requirements relative to the three levels of inputs used to measure fair value in accordance with Topic 820, “Fair Value Measurement.” The adoption of this new guidance did not have any impact on the Company’s results of operations, cash flows, and financial condition.

7

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Unaudited Condensed Consolidated Financial Statements

June 30, 2020

(Unaudited)

2. Trademarks and Other Intangibles

Trademarks and other intangibles, net consist of the following:

	Weighted
	Average	June 30, 2020
	Amortization	Gross Carrying		Accumulated		Net Carrying
($ in thousands)	Period	Amount		Amortization		Amount
Trademarks (indefinite-lived)	n/a	$	44,500	$	—	$	44,500
Trademarks (finite-lived)	15 years		34,613		5,714		28,899
Trademarks (finite-lived)	18 years		38,194		3,129		35,065
Other intellectual property	7 years		762		482		280
Copyrights and other intellectual property	10 years		190		119		71
Total		$	118,259	$	9,444	$	108,815

	Weighted
	Average	December 31, 2019
	Amortization	Gross Carrying		Accumulated		Net Carrying
($ in thousands)	Period	Amount		Amortization		Amount
Trademarks (indefinite-lived)	n/a	$	62,900	$	—	$	62,900
Trademarks (finite-lived)	15 years		16,213		4,560		11,653
Trademarks (finite-lived)	18 years		38,194		2,067		36,127
Other intellectual property	7 years		762		428		334
Copyrights and other intellectual property	10 years		190		109		81
Total		$	118,259	$	7,164	$	111,095

Amortization expense for intangible assets was approximately $1.14 million for the three-month period ended June 30, 2020 (the "current quarter") and was approximately $0.83 million for the three-month period ended June 30, 2019 (the "prior year quarter"). Amortization expense for intangible assets was approximately $2.28 million for the six-month period ended June 30, 2020 (the “current six months”) and was approximately $1.60 million for the six-month period ended June 30, 2019 (the “prior year six months”).

Effective January 1, 2020, the Company determined that the Ripka Brand, inclusive of all its trademarks, has a finite life of 15 years, and is amortized on a straight-line basis accordingly. Prior to January 1, 2020, the Ripka Brand trademarks were considered indefinite-lived assets.

The trademarks related to the Isaac Mizrahi Brand have been determined to have indefinite useful lives and, accordingly, no amortization has been recorded for these assets.

8

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Unaudited Condensed Consolidated Financial Statements

June 30, 2020

(Unaudited)

3. Significant Contracts

QVC Agreements

Under the Company’s agreements with QVC, QVC is required to pay the Company fees based primarily on a percentage of its net sales of Isaac Mizrahi, Ripka, and H Halston branded merchandise. QVC royalty revenue represents a significant portion of the Company’s total revenues.

● Total revenues from QVC totaled $4.04 million and $5.94 million for the current and prior year quarter, respectively, representing approximately 81% and 65% of the Company’s total net revenues for the current and prior year quarter, respectively.

● Total revenues from QVC totaled $8.74 million and $12.77 million for the current and prior year six months, respectively, representing approximately 60% and 66% of the Company’s total net revenues for the current and prior year six months, respectively.

● As of June 30, 2020 and December 31, 2019, the Company had receivables from QVC of $3.94 million and $4.33 million, respectively, representing approximately 60% and 41% of the Company’s total receivables, respectively.

4. Allowance for Doubtful Accounts

Accounts receivable are presented on the Company’s condensed consolidated balance sheets net of allowances of $793,000 and $155,000 as of June 30, 2020 and December 31, 2019, respectively. The Company recognized bad debt expense of $472,000 and $0 for the current quarter and prior year quarter, respectively, and recognized bad debt expense of $683,000 and $(144,000) for the current six months and prior year six months, respectively.

Included within these amounts, the current quarter and current six months reflect $472,000 and $586,000, respectively, of bad debt expense related to the bankruptcy of a large retail customer due to the novel coronavirus disease pandemic. The total allowance of $586,000 against such customer’s outstanding receivable balance of $1,172,000 million at June 30, 2020 represents management’s best estimate of collectibility, based on information currently available.

5. Leases

The Company has operating leases for its current office, former office, and certain equipment with a term of 12 months or less. The Company’s office leases have remaining lease terms of approximately 2 years to 8 years.

Under GAAP, a lessee is generally required to recognize a liability for its obligation to make future lease payments (the lease liability) and a right-of-use (“ROU”) asset representing its right to use the underlying leased asset for the lease term. The Company determines if an arrangement is a lease at inception. Operating leases are recorded in operating lease ROU assets, current portion of operating lease liabilities, and long-term operating lease liabilities on the Company’s condensed consolidated balance sheets. The Company does not recognize lease liabilities and ROU assets for lease terms of 12 months or less, but recognizes such lease payments in net income on a straight-line basis over the lease terms.

Operating lease ROU assets and lease liabilities are recognized at commencement date based on the present value of lease payments over the lease term. As most of the Company’s leases do not provide an implicit rate, the Company generally uses its incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. Lease terms may include options to extend or terminate the lease when it is reasonably certain

9

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Unaudited Condensed Consolidated Financial Statements

June 30, 2020

(Unaudited)

that the Company will exercise that option. Lease expense for operating lease payments is recognized on a straight-line basis over the lease term.

For the current and prior year quarter, lease expense included in selling, general and administrative expenses on the Company’s unaudited condensed consolidated statements of operations was $0.4 million. For the current and prior year six months, lease expense included in selling, general and administrative expenses on the Company’s unaudited condensed consolidated statements of operations was $0.8 million.

As of June 30, 2020, the weighted average remaining operating lease term was 6.4 years and the weighted average discount rate for operating leases was 6.3%.

Cash paid for amounts included in the measurement of operating lease liabilities was $0.6 million in the prior year quarter, $0.6 million in the current six months, and $1.2 million in the prior year six months. No such cash payments for operating lease liabilities were made during the current quarter, and the $0.6 million amount of such payments due to lessors are recorded as accounts payable in the Company’s unaudited condensed consolidated balance sheet at June 30, 2020. The Company intends to settle or otherwise satisfy such obligations in subsequent periods.

As of June 30, 2020, the maturities of lease liabilities, excluding the aforementioned amounts reflected as accounts payable, were as follows:

($ in thousands)
Remainder of 2020	$	1,212
2021		2,577
2022		1,732
2023		1,552
2024		1,552
After 2024		4,398
Total lease payments		13,023
Less: Discount		2,361
Present value of lease liabilities		10,662
Current portion of lease liabilities		1,873
Non-current portion of lease liabilities	$	8,789

6. Debt

The Company’s net carrying amount of debt was comprised of the following:

	June 30,		December 31,
($ in thousands)	2020		2019
Xcel Term Loan	$	18,250	$	19,000
Unamortized deferred finance costs related to term loan		(129)		(179)
Economic Injury Disaster Loan		10		—
Total		18,131		18,821
Current portion of long-term debt		2,900		2,250
Long-term debt	$	15,231	$	16,571

10

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Unaudited Condensed Consolidated Financial Statements

June 30, 2020

(Unaudited)

Xcel Term Loan

On February 11, 2019, the Company entered into an amended loan agreement with Bank Hapoalim B.M. (“BHI”), which amended and restated the prior Xcel Term Loan. Immediately prior to February 11, 2019, the aggregate principal amount of the prior Xcel Term Loan was $14.5 million. Pursuant to the Xcel Term Loan agreement, the Lenders extended to Xcel an additional term loan in the amount of $7.5 million, such that, as of February 11, 2019, the aggregate outstanding balance of all the term loans extended by BHI to Xcel was $22.0 million, which amount was divided under the Xcel Term Loan agreement into two term loans: (1) a term loan in the amount of $7.3 million (“Term Loan A”) and (2) a term loan in the amount of $14.7 million (“Term Loan B” and, together with Term Loan A, the “Term Loans”).

The terms and conditions of the Xcel Term Loan resulted in significantly different debt service payment requirements compared with the prior term debt with BHI. Management assessed and determined that this amendment resulted in a loss on extinguishment of debt and recognized a loss of $0.2 million (consisting of unamortized deferred finance costs) during the prior year quarter. Upon entering into the Xcel Term Loan, Xcel paid an upfront fee in the amount of $0.09 million to BHI.

The Xcel Term Loan also allows that BHI and any other lender party to the Xcel Term Loan (collectively, the “Lenders”) can provide to Xcel a revolving loan facility and a letter of credit facility, the terms of each of which shall be agreed to by Xcel and the Lenders. Amounts advanced under the revolving loan facility (the “Revolving Loans”) will be used for the purpose of consummating acquisitions by Xcel or its subsidiaries that are or become parties to the Xcel Term Loan. Xcel will have the right to convert Revolving Loans to incremental term loans (the “Incremental Term Loans”) in minimum amounts of $5.0 million. The Company has not drawn down any funds under either the revolving loan facility or letter of credit facility.

On April 13, 2020, the Company amended its Second Amended and Restated Loan and Security Agreement with BHI. Under this amendment, the quarterly installment payment due March 31, 2020 was deferred, and the amounts of the quarterly installment payments due throughout the remainder of 2020 were reduced, while the amount of principal to be repaid through variable payments based on excess cash flow was increased. In addition, there were multiple changes and waivers to the various financial covenants. Further, this amendment permitted Xcel to incur unsecured debt through the Paycheck Protection Program (“PPP”) under the Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”), and excludes any associated PPP debt and debt service from the covenant calculations. There were no changes to the total principal balance, interest rate, or maturity date.

On August 18, 2020, the Company further amended its Second Amended and Restated Loan and Security Agreement with BHI. Under this amendment, the amounts of the quarterly installment payments due throughout 2021 were reduced, and the amount of principal to be repaid through variable payments based on excess cash flow was increased. In addition, there were multiple changes and waivers to the various financial covenants. There were no changes to the total principal balance, interest rate, or maturity date.

The Term Loans mature on December 31, 2023; Incremental Term Loans shall mature on the date set forth in the applicable term note; and Revolving Loans and the letter of credit facility shall mature on such date as agreed upon by Xcel and the Lenders. Any letter of credit issued under Xcel Term Loan shall terminate no later than one year following the date of issuance thereof.

11

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Unaudited Condensed Consolidated Financial Statements

June 30, 2020

(Unaudited)

The remaining principal balance of the Xcel Term Loan, as amended, outstanding at June 30, 2020 is payable in fixed installments as set forth in the following table, plus the variable payments as described below:

($ in thousands)
Installment Payment Dates	Amount
September 30, 2020 and December 31, 2020	$	750
March 31, 2021, June 30, 2021, September 30, 2021, and December 31, 2021	$	700
March 31, 2022, June 30, 2022, September 30, 2022, and December 31, 2022	$	1,125
March 31, 2023, June 30, 2023, September 30, 2023, and December 31, 2023	$	1,250

In addition to the fixed installments outlined above, commencing with the fiscal quarter ended March 31, 2021, the Company is required to repay a portion of the Xcel Term Loan in an amount equal to 50% of the excess cash flow for the fiscal quarter, provided that no early termination fee shall be payable with respect to any such payment. Excess cash flow means, for any period, cash flow from operations (before certain permitted distributions) less (i) capital expenditures not made through the incurrence of indebtedness, (ii) all cash principal paid or payable during such period, and (iii) all dividends declared and paid (or which could have been declared and paid) during such period to equity holders of any credit party treated as a disregarded entity for tax purposes. To the extent that the cumulative amount of such variable repayments made is less than $4.45 million as of March 31, 2022, any such shortfall must be repaid at that date.

Thus, the aggregate remaining annual scheduled principal payments under the Xcel Term Loan are as follows:

	Amount of
($ in thousands)	Principal
Year Ending December 31,	Payment
2020	$	1,500
2021		2,800
2022		8,950
2023		5,000
Total	$	18,250

Xcel has the right to prepay the Term Loans, Incremental Term Loans, Revolving Loans, and obligations with respect to letters of credit and accrued and unpaid interest thereon and to terminate the Lenders’ obligations to make Revolving Loans and issue letters of credit; provided that any prepayment of less than all of the outstanding balances of the Term Loans and Incremental Term Loans shall be applied to the remaining amounts due in inverse order of maturity.

If any Term Loan or any Incremental Term Loan is prepaid on or prior to the third anniversary of the Closing Date (including as a result of an event of default), Xcel shall pay an early termination fee as follows: an amount equal to the principal amount of the Term Loan or Incremental Term Loan, as applicable, being prepaid, multiplied by: (i) two percent (2.00%) if any of Term Loan B or any Incremental Term Loan is prepaid on or before the second anniversary of the later of the Closing Date or the date such Incremental Term Loan was made, as applicable; (ii) one percent (1.00%) if any of Term Loan A is prepaid on or before the second anniversary of the Closing Date; (iii) one percent (1.00%) if any of Term Loan B or any Incremental Term Loan is prepaid after the second anniversary of the later of the Closing Date or such Incremental Term Loan was made, as applicable, but on or before the third anniversary of such date; (iv) one-half of one percent (0.50%) if any of Term Loan A is prepaid after the second anniversary of the Closing Date, but on or before the third anniversary of such date; or (v) zero percent (0.00%) if any Term Loan or any Incremental Term Loan is prepaid after the third anniversary of the later of the Closing Date or the date such Incremental Term Loan was made, as applicable.

12

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Unaudited Condensed Consolidated Financial Statements

June 30, 2020

(Unaudited)

Notwithstanding the above, Xcel may make a voluntary prepayment of up to $0.75 million without any early termination fees. Any such prepayment would be applied against the April 30, 2021 fixed installment payment and would be excluded from the computation of excess cash flows.

Xcel’s obligations under the Xcel Term Loan are guaranteed by and secured by all of the assets of Xcel and its wholly owned subsidiaries, as well as any subsidiary formed or acquired that becomes a credit party to the Xcel Term Loan agreement (the “Guarantors”) and, subject to certain limitations contained in Xcel Term Loan, equity interests of the Guarantors. Xcel also granted the Lenders a right of first offer to finance any acquisition for which the consideration will be paid other than by cash of Xcel or by the issuance of equity interest of Xcel.

Interest on Term Loan A accrues at a fixed rate of 5.1% per annum and is payable on each day on which the scheduled principal payments on Term Loans are required to be made. Interest on Term Loan B accrues at a fixed rate of 6.25% per annum and is payable on each day on which the scheduled principal payments on Term Loans are required to be made. Interest on the Revolving Loans will accrue at either the Base Rate or LIBOR, as elected by Xcel, plus a margin to be agreed to by Xcel and the Lenders and will be payable on the first day of each month. Base Rate is defined in the Xcel Term Loan agreement as the greater of (a) BHI’s stated prime rate or (b) 2.00% per annum plus the overnight federal funds rate published by the Federal Reserve Bank of New York. Interest on the Incremental Term Loans will accrue at rates to be agreed to by Xcel and the Lenders and will be payable on each day on which the scheduled principal payments under the applicable note are required to be made.

The Xcel Term Loan contains customary covenants, including reporting requirements, trademark preservation, and the following financial covenants of Xcel (on a consolidated basis with Xcel and the Guarantors under the Second Amended and Restated Loan and Security Agreement):

● net worth of at least $90.0 million at the end of each fiscal quarter;

● liquid assets of at least $3.0 million through December 31, 2020, at least $2.5 million for the fiscal quarters ending March 31, 2021 through September 30, 2021, at least $3.0 million for the fiscal quarter ending December 31, 2021, and at least $5.0 million thereafter;

● EBITDA shall not be less than $5.0 million for the twelve fiscal month period ended March 31, 2020, $4.8 million for the twelve fiscal month period ending June 30, 2020, and $5.0 million for the twelve month fiscal period ending September 30, 2020;

● the fixed charge coverage ratio for the twelve fiscal month period ending at the end of each fiscal quarter shall not be less than the ratio set forth below:

Fiscal Quarter End	Fixed Charge Coverage Ratio
December 31, 2020, March 31, 2021, June 30, 2021, September 30, 2021, and December 31, 2021	1.25 to 1.00
March 31, 2022, and thereafter	1.10 to 1.00

● capital expenditures (excluding any capitalized compensation costs) shall not exceed $1.6 million for the fiscal year ending December 31, 2020, and $0.7 million for any fiscal year beginning after December 31, 2020; and

13

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Unaudited Condensed Consolidated Financial Statements

June 30, 2020

(Unaudited)

● the leverage ratio for the twelve fiscal month period ending at the end of each fiscal period set forth below shall not exceed the ratio below:

Fiscal Period	Maximum Leverage Ratio
June 30, 2020	4.25 to 1.00
September 30, 2020	4.00 to 1.00
December 31, 2020	3.50 to 1.00
March 31, 2021	3.15 to 1.00
June 30, 2021	3.00 to 1.00
September 30, 2021	2.75 to 1.00
December 31, 2021	2.50 to 1.00
March 31, 2022 and each Fiscal Quarter end thereafter	1.50 to 1.00

The Company was in compliance with all applicable covenants as of June 30, 2020.

For the current and prior year quarter, the Company incurred aggregate interest expense related to term loan debt of approximately $285,000 and $326,000, respectively. For the current six months and prior year six months, the Company incurred aggregate interest expense related to term loan debt of approximately $572,000 and $586,000, respectively. The effective interest rate related to term loan debt was approximately 6.6% for the current quarter and current six months, and approximately 6.8% for the prior year quarter and prior year six months.

PPP Loan

On April 20, 2020, the Company executed a promissory note (the “Promissory Note”) with Bank of America, N.A., which provides for an unsecured loan in the amount of $1.806 million (the “PPP Loan”), pursuant to the PPP under the CARES Act. The PPP Loan has a two-year term and bears interest at a fixed rate of 1.0% per annum. Monthly principal and interest payments are deferred for six months after the date of disbursement. The PPP Loan may be prepaid at any time prior to maturity with no prepayment penalties. The Promissory Note contains events of default and other provisions customary for a loan of this type. The PPP Loan was funded on April 23, 2020.

The PPP also provides that the PPP Loan may be partially or wholly forgiven if the funds are used for certain qualifying expenses as described in the CARES Act, and later amended by the Paycheck Protection Program Flexibility Act (the "Flexibility Act") signed into law on June 5, 2020. Such forgiveness will be determined, subject to limitations, based on the use of loan proceeds for payment of payroll costs and any payments of mortgage interest, rent, and utilities. While management believes that it is probable that the PPP Loan will be forgiven in full, no definite assurance can be provided that forgiveness for any portion of the PPP Loan will be obtained. Management's determination that full forgiveness is probable is based on qualification under the Flexibility Act.

Management evaluated the legal and contractual terms associated with the PPP Loan, and concluded that, although the legal form of the PPP Loan is debt, the PPP Loan represents in substance a government grant that is expected to be forgiven. Given the lack of definitive authoritative guidance under GAAP for accounting for government grants, the Company analogized to accounting guidance under International Accounting Standard 20, “Accounting for Government Grants and Disclosure of Government Assistance.” Under such guidance, once it is probable that the conditions attached to the assistance will be met, the earnings impact of government grants is recorded on a systematic basis over the periods in which the entity recognizes as expenses the related costs for which the grants are intended to compensate. Accordingly, the Company recognized approximately $1,640,000 as a reduction to operating expenses in the current quarter. The remaining amount of $166,000 as of June 30, 2020 is recorded as a deferred credit within accounts payable, accrued expense and other current liabilities in the accompanying condensed consolidated balance sheets, and will be recognized

14

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Unaudited Condensed Consolidated Financial Statements

June 30, 2020

(Unaudited)

as a reduction to operating expenses in the quarter ending September 30, 2020. No interest expense related to the PPP Loan has been recorded in the Company’s unaudited condensed consolidated financial statements.

Economic Injury Disaster Loan

On May 4, 2020, the Company received a $10,000 loan through the U.S. Small Business Administration’s disaster assistance program. This loan has a thirty-year term and bears interest at a fixed rate of 3.75% per annum.

7.Stockholders’ Equity

2011 Equity Incentive Plan

The Company’s 2011 Equity Incentive Plan, as amended and restated (the “Plan”), is designed and utilized to enable the Company to provide its employees, officers, directors, consultants, and others whose past, present, and/or potential contributions to the Company have been, are, or will be important to the success of the Company, an opportunity to acquire a proprietary interest in the Company. A total of 13,000,000 shares of common stock are eligible for issuance under the Plan. The Plan provides for the grant of any or all of the following types of awards: stock options, restricted stock, deferred stock, stock appreciation rights, and other stock-based awards. The Plan is administered by the Company’s Board of Directors, or, at the Board’s discretion, a committee of the Board.

The Company accounts for stock-based compensation in accordance with ASC Topic 718, “Compensation - Stock Compensation,” by recognizing the fair value of stock-based compensation as an operating expense over the service period of the award or term of the corresponding contract, as applicable.

The fair value of options and warrants is estimated on the date of grant using the Black-Scholes option pricing model. The valuation determined by the Black-Scholes option pricing model is affected by the Company’s stock price as well as assumptions regarding a number of highly complex and subjective variables. These variables include, but are not limited to, expected stock price volatility over the term of the awards, and actual and projected employee stock option exercise behaviors. The risk-free rate is based on the U.S. Treasury rate for the expected life at the time of grant, volatility is based on the average long-term implied volatilities of peer companies, and expected life is based on the estimated average of the life of options and warrants using the simplified method. The Company utilizes the simplified method to determine the expected life of the options and warrants due to insufficient exercise activity during recent years as a basis from which to estimate future exercise patterns. The expected dividend assumption is based on the Company’s history and expectation of dividend payouts.

Restricted stock awards are valued using the fair value of the Company’s stock at the date of grant.

The Company accounts for non-employee awards in accordance with ASU 2018-07, “Compensation - Stock Compensation (Topic 718) - Improvements to Nonemployee Share-Based Payment Accounting.” Such awards are measured at the grant-date fair value of the equity instruments to be issued, and the Company recognizes compensation cost for grants to non-employees on a straight-line basis over the period of the grant.

For stock option awards for which vesting is contingent upon the achievement of certain performance targets, the timing and amount of compensation expense recognized is based upon the Company’s projections and estimates of the relevant performance metric(s) until the time the performance obligation is satisfied.

Forfeitures are accounted for as a reduction of compensation cost in the period when such forfeitures occur.

15

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Unaudited Condensed Consolidated Financial Statements

June 30, 2020

(Unaudited)

Stock Options

Options granted under the Plan expire at various times - either five, seven, or ten years from the date of grant, depending on the particular grant.

A summary of the Company’s stock options activity for the current six months is as follows:

				Weighted
				Average
		Weighted		Remaining
		Average		Contractual	Aggregate
	Number of	Exercise		Life	Intrinsic
	Options	Price		(in Years)	Value
Outstanding at January 1, 2020	7,222,625	$	3.33	5.82	$	—
Granted	443,500		1.47
Canceled	—		—
Exercised	—		—
Expired/Forfeited	(126,000)		1.81
Outstanding at June 30, 2020, and expected to vest	7,540,125	$	3.32	5.31	$	—
Exercisable at June 30, 2020	2,939,625	$	5.04	1.62	$	—

On January 1, 2020, the Company granted options to purchase 5,000 shares of stock to a board observer. The exercise price of the options is $4.00 per share, and 50% of the options vest on each of January 1, 2021 and January 1, 2022.

On January 31, 2020, the Company granted options to purchase 75,000 shares of stock to a consultant. The exercise price of the options is $1.57 per share, and all options vested immediately on the date of grant.

On February 28, 2020, the Company granted options to purchase 50,000 shares of common stock to an employee. The exercise price is $1.40 per share, and the vesting of such options is dependent upon the Company achieving certain 12-month sales targets through December 31, 2021.

On March 13, 2020, the Company granted options to purchase 50,000 shares of common stock to a certain key employee. The exercise price of the options is $5.50 per share, and all options vested immediately on the date of grant.

On March 31, 2020, the Company granted options to purchase 50,000 shares of common stock to an employee. The exercise price of the options is $0.61 per share, and one-third of the options shall vest on each of March 31, 2021, March 31, 2021, and March 31, 2022.

On April 1, 2020, the Company granted options to purchase an aggregate of 200,000 shares of commons stock to non-management directors. The exercise price of the options is $0.50 per share, and 50% of the options shall vest on each of April 1, 2021 and April 1, 2022.

On April 15, 2020, the Company granted options to purchase 13,500 shares of common stock to a consultant. The exercise price of the options is $3.00 per share. One-third of the options vested on June 30, 2020, and one-third of the options shall vest on each of September 30, 2020 and December 31, 2020.

Compensation expense related to stock options for the current quarter and the prior year quarter was approximately $45,000 and $73,000, respectively. Compensation expense related to stock options for the current six months and prior year six months was approximately $113,000 and $316,000, respectively.

16

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Unaudited Condensed Consolidated Financial Statements

June 30, 2020

(Unaudited)

Total unrecognized compensation expense related to unvested stock options at June 30, 2020 amounts to approximately $250,000 and is expected to be recognized over a weighted average period of approximately 1.50 years.

A summary of the Company’s non-vested stock options activity for the current six months is as follows:

		Weighted
		Average
	Number of	Grant Date
	Options	Fair Value
Balance at January 1, 2020	4,551,500	$	0.18
Granted	443,500		0.13
Vested	(279,500)		0.68
Forfeited or Canceled	(115,000)		0.34
Balance at June 30, 2020	4,600,500	$	0.14

Warrants

Warrants expire at various times - either five or ten years from the date of grant, depending on the particular grant.

A summary of the Company’s warrants activity for the current six months is as follows:

				Weighted
				Average
		Weighted		Remaining
		Average		Contractual	Aggregate
	Number of	Exercise		Life	Intrinsic
	Warrants	Price		(in Years)	Value
Outstanding and exercisable at January 1, 2020	579,815	$	4.63	2.32	$	—
Granted	—		—
Canceled	—		—
Exercised	—		—
Expired/Forfeited	—		—
Outstanding and exercisable at June 30, 2020	579,815	$	4.63	1.81	$	—

No compensation expense related to warrants was recognized in the current quarter, current six months, prior year quarter, or prior year six months.

17

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Unaudited Condensed Consolidated Financial Statements

June 30, 2020

(Unaudited)

Stock Awards

A summary of the Company’s restricted stock activity for the current six months is as follows:

		Weighted
	Number of	Average
	Restricted	Grant Date
	Shares	Fair Value
Outstanding at January 1, 2020	1,230,623	$	4.33
Granted	607,428		0.80
Canceled	—		—
Vested	(1,057,218)		2.47
Expired/Forfeited	—		—
Outstanding at June 30, 2020	780,833	$	4.09

On March 30, 2020, the Company issued 336,700 shares of stock to a member of senior management as payment for a performance bonus earned in 2019. These shares vested immediately.

On May 20, 2020, the Company issued an aggregate of 270,728 shares of stock to its employees. These shares vested immediately. The Company recognized approximately $265,000 of compensation expense in the current quarter and current six months related to this grant.

Compensation expense related to restricted stock grants for the current and prior year quarter was approximately $10,000 and $104,000, respectively. Compensation expense related to restricted stock grants for the current six months and prior year six months was approximately $33,000 and $166,000, respectively.

Total unrecognized compensation expense related to unvested restricted stock grants at June 30, 2020 amounts to approximately $32,000 and is expected to be recognized over a weighted average period of approximately 0.75 years.

The Company also recognized approximately $168,000 and $320,000 of compensation expense in the current quarter and current six months related to certain senior management bonuses payable in stock in 2021.

Shares Available Under the Company’s 2011 Equity Incentive Plan

As of June 30, 2020, there were 1,218,670 shares of common stock available for issuance under the Plan.

Shares Reserved for Issuance

As of June 30, 2020, there were 9,338,610 shares of common stock reserved for issuance pursuant to unexercised warrants and stock options, or available for issuance under the Plan.

Dividends

The Company has not paid any dividends to date.

18

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Unaudited Condensed Consolidated Financial Statements

June 30, 2020

(Unaudited)

8.    Earnings Per Share

Basic earnings per share (“EPS”) is computed by dividing net income (loss) available to common stockholders by the weighted average number of common shares outstanding during the period. Diluted EPS gives effect to all potentially dilutive common shares outstanding during the period, including stock options and warrants, using the treasury stock method. Diluted EPS excludes all potentially dilutive shares of common stock if their effect is anti-dilutive.

	Three Months Ended		Six Months Ended
	June 30,		June 30,
	2020	2019	2020	2019
Basic	19,132,244	18,976,394	19,001,321	18,770,378
Effect of exercise of warrants	—	657	—	675
Diluted	19,132,244	18,977,051	19,001,321	18,771,053

As a result of the net loss presented for the current quarter and current six months, the Company calculated diluted earnings per share using basic weighted average shares outstanding for such period, as utilizing diluted shares would be anti-dilutive to loss per share.

The computation of diluted EPS excludes the following potentially dilutive securities because their inclusion would be anti-dilutive:

	Three Months Ended		Six Months Ended
	June 30,		June 30,
	2020	2019	2020	2019
Stock options and warrants	8,119,940	8,408,386	8,119,940	7,124,005

9.    Income Tax

The effective income tax rate for the current quarter and the prior year quarter was approximately -49% and 37%, respectively, resulting in an income tax (benefit) provision of $0.43 million and $1.07 million, respectively.

The effective income tax rate for the current six months and prior year six months was approximately 5% and 37%, respectively, resulting in an income tax (benefit) provision of $(0.12) million and $1.14 million, respectively.

For the current quarter, the federal statutory rate differed from the effective tax rate primarily due to the tax impact from the vesting of restricted shares of common stock, which was treated as a discrete item for tax purposes and decreased the effective rate by approximately 41%. The effective tax rate was also attributable to state taxes and recurring permanent differences, which decreased the effective tax rate by approximately 2% and 27%, respectively. The effective tax rate was also affected by the tax impact of a potential federal net operating loss carryback due to the CARES Act; this item increased the effective rate by approximately 3%.

For the prior year quarter, the federal statutory rate differed from the effective tax rate primarily due to state taxes and recurring permanent differences, which increased the effective tax rate by approximately 9% and 6%, respectively.

For the current six months, the federal statutory rate differed from the effective tax rate primarily due to the tax impact from the vesting of restricted shares of common stock, which was treated as a discrete item for tax purposes and decreased the effect rate by approximately 16%. The effective rate was also attributable to state taxes and recurring permanent differences, which increased the effective tax rate by approximately 5% and decreased the effective tax rate by

19

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Unaudited Condensed Consolidated Financial Statements

June 30, 2020

(Unaudited)

approximately 8%, respectively. The effective tax rate was also affected by the tax impact of a potential federal net operating loss carryback due to the CARES Act; this item increased the effective rate by approximately 4%.

For the prior year six months, the federal statutory rate differed from the effective tax rate primarily due to state taxes and recurring permanent differences, which increased the effective tax rate by approximately 9% and 6%, respectively.

On March 27, 2020, the CARES Act was enacted and signed into law. The CARES Act includes certain provisions impacting businesses’ income taxes related to 2018, 2019, and 2020. Some of the significant tax law changes are to increase the limitation on deductible business interest expense for 2019 and 2020, allow for the five-year carryback of net operating losses for 2018-2020, suspend the 80% limitation of taxable income for net operating loss carryforwards for 2018-2020, provide for the acceleration of depreciation expense from 2018 and forward on qualified improvement property, and accelerate the ability to claim refunds of AMT credit carryforwards. The Company is required to recognize the effect of tax law changes on its financial statements in the period in which the law was enacted. At this time, the Company may avail itself of the ability to carry back net operating losses generated in 2018 and 2019 tax years for five years, resulting in an estimated income statement benefit of $98,000 and tax refund receivable of $203,000.

20

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Unaudited Condensed Consolidated Financial Statements

June 30, 2020

(Unaudited)

10.    Related Party Transactions

Benjamin Malka

Benjamin Malka was a director of the Company from June 2014 through September 2019. Mr. Malka is also a 25% equity holder of House of Halston LLC (“HOH”), and is the former Chief Executive Officer of HOH. HOH is the parent company of the H Company IP, LLC (“HIP”).

On February 11, 2019, the Company and its wholly owned subsidiary, H Heritage Licensing, LLC, entered into an asset purchase agreement (the "Heritage Asset Purchase Agreement") with HIP and HOH, pursuant to which the Company acquired certain assets of HIP, including the "Halston," "Halston Heritage," and "Roy Frowick" trademarks (collectively, the "Halston Heritage Trademarks") and other intellectual property rights relating thereto.

Pursuant to the Heritage Asset Purchase Agreement, at closing, the Company delivered in escrow for HIP or its designees (collectively, the “Sellers”) an aggregate of $8.4 million in cash and 777,778 shares of the Company’s common stock valued at $1.1 million (the “Xcel Shares”), subject to a voting agreement and a lock-up agreement relating to the Xcel Shares and a consent and waiver agreement each in form satisfactory to Xcel within three months from the date of the Heritage Asset Purchase Agreement. Such agreements were executed and delivered to Xcel, and the Xcel Shares were issued and delivered to the Sellers.

In addition to the closing considerations, HIP is eligible to earn up to an aggregate of $6.0 million (the “Earn-Out Value”) through December 31, 2022 based on Excess Net Royalties. “Excess Net Royalties” during any calendar year for 2019 through 2022 (each, a “Royalty Target Year”) is equal to (a) the positive amount, if any, of the Net Royalties as calculated for such Royalty Target Year, less the greater of (i) One Million Five Hundred Thousand Dollars ($1.5 million), or (ii) the maximum Net Royalties for any previous Royalty Target Year. “Applicable Percentage” means (a) 50% of the first $10.0 million of Excess Net Royalties during the Earn-Out Period, (b) 20% of aggregate Excess Net Royalties during the Earn-Out Period greater than $10.0 million and up to $15.0 million and (c) 0% of aggregate Excess Net Royalties during the Earn-Out Period in excess of $15.0 million. The Earn-Out Consideration shall be payable in common stock of Xcel (the “Earn-Out Shares”); provided, however, that if the number of Earn-Out Shares, when combined with the number of Xcel Shares issued at the Closing Date, will exceed 4.99% of the aggregate number of shares of Xcel common stock outstanding as of the Closing Date (calculated in accordance with Nasdaq Rule 5635(a)) (the “Xcel Share Limit”), then Xcel may, in its sole and unfettered discretion, elect to (x) pay cash for the Earn-Out Value attributable to the Earn-Out Shares that would exceed the Xcel Share Limit; (y) solicit stockholder approval for the issuance of Earn-Out Shares in excess of the Xcel Share Limit in accordance with Nasdaq Rule 5635(a)(2) and, if such stockholder approval is obtained, issue such Earn-Out Shares to HIP; or (z) solicit stockholder approval for the issuance of Shares in excess of the Xcel Share Limit in accordance with Nasdaq Rule 5635(a)(2) and, if such stockholder approval is obtained, pay the applicable Earn-Out Consideration with a combination of cash and Earn-Out Shares.

Robert W. D’Loren

Jennifer D’Loren is the wife of Robert W. D’Loren, the Company’s Chief Executive Officer and Chairman of the Board, and is employed by the Company. Mrs. D’Loren brings vast experience in project management and implementation of financial IT solutions. During the past two years, Mrs. D’Loren has worked on the implementation of the Company’s ERP system. Mrs. D’Loren received compensation of $33,000 and $44,000 for the current quarter and prior year quarter, respectively. Mrs. D’Loren received compensation of $70,000 and $83,000 for the current six months and prior year six months, respectively.

21

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Unaudited Condensed Consolidated Financial Statements

June 30, 2020

(Unaudited)

11.    Commitments and Contingencies

Contingent Obligation 

In connection with the February 11, 2019 purchase of the Halston Heritage Trademarks from HIP, the Company agreed to pay HIP additional consideration (the “Halston Heritage Earn-Out”) of up to an aggregate of $6.0 million, based on royalties earned through December 31, 2022. The Halston Heritage Earn-Out of $0.9 million is recorded as a long-term liability at June 30, 2020 and December 31, 2019 in the accompanying condensed consolidated balance sheets, based on the difference between the fair value of the acquired assets of the Halston Heritage Trademarks and the total consideration paid. In accordance with Accounting Standards Codification (“ASC”) Topic 480, “Distinguishing Liabilities from Equity,” the Halston Heritage Earn-Out obligation is treated as a liability in the accompanying condensed consolidated balance sheets because of the variable number of shares payable under the agreement.

Coronavirus Pandemic

In March 2020, the World Health Organization declared the outbreak of a novel coronavirus disease (“COVID-19”) as a pandemic, which continues to spread throughout the U.S. COVID-19 is having an unprecedented impact on the U.S. economy as federal, state, and local governments react to this public health crisis.

The impacts of the current COVID-19 pandemic are broad reaching and are having an impact on the Company’s licensing and wholesale businesses. The COVID-19 pandemic is impacting the Company’s supply chain as most of the Company’s products are manufactured in China, Thailand, and other places around the world affected by this event. Temporary factory closures and the pace of workers returning to work have impacted contract manufacturers’ ability to source certain raw materials and to produce finished goods in a timely manner. The outbreak is also impacting distribution and logistics providers' ability to operate in the normal course of business. Further, the pandemic has resulted in a sudden and continuing decrease in sales for many of the Company’s products, resulting in order cancellations.

Due to the COVID-19 outbreak, there is significant uncertainty surrounding the potential impact on the Company’s future results of operations and cash flows. Continued impacts of the pandemic could materially adversely affect the Company’s near-term and long-term revenues, earnings, liquidity, and cash flows as the Company’s customers and/or licensees may request temporary relief, delay, or not make scheduled payments.

12.    Subsequent Events

On August 6, 2020, the Company entered into an assignment and assumption agreement with the landlord and subtenant at its former office location at 475 Tenth Avenue, New York, NY. Under the terms of this agreement, in exchange for certain consideration totaling approximately $887,000, the landlord agreed to release the Company from all future obligations under the lease effective as of August 1, 2020, and all of the Company’s rights, title, and interest in and to the lease at 475 Tenth Avenue was assigned to the current subtenant in place.

On August 18, 2020, the Company further amended its Second Amended and Restated Loan and Security Agreement with BHI. Under this amendment, the amounts of the quarterly installment payments due throughout 2021 were reduced, and the amount of principal to be repaid through variable payments based on excess cash flow was increased. In addition, there were multiple changes and waivers to the various financial covenants. There were no changes to the total principal balance, interest rate, or maturity date. See Note 6, “Debt,” for additional information.

22

ITEM 2.    MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995. The statements that are not historical facts contained in this report are forward-looking statements that involve a number of known and unknown risks, uncertainties and other factors, all of which are difficult or impossible to predict and many of which are beyond our control, which may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. These risks are detailed in the Risk Section of our Form 10-K for the fiscal year ended December 31, 2019. The words “believe,” “anticipate,” “expect,” “continue,” “estimate,” “appear,” “suggest,” “goal,” “potential,” “predicts,” “seek,” “will,” “confident,” “project,” “provide,” “plan,” “likely,” “future,” “ongoing,” “intend,” “may,” “should,” “would,” “could,” “guidance,” and similar expressions identify forward-looking statements.

Overview

Xcel Brands, Inc. (“Xcel,” the “Company,” “we,” “us,” or “our”) is a media and consumer products company engaged in the design, production, marketing, wholesale distribution, and direct-to-consumer sales of branded apparel, footwear, accessories, jewelry, home goods and other consumer products, and the acquisition of dynamic consumer lifestyle brands. Xcel was founded by Robert W. D’Loren in 2011 with a vision to reimagine shopping, entertainment, and social as one. The Company owns and manages the Isaac Mizrahi brands (the "Isaac Mizrahi Brand"), the Judith Ripka brands (the "Ripka Brand"), the Halston brands ("Halston Brand"), and the C Wonder brands (the "C Wonder Brand”). The Company also owns and manages the Longaberger brand (the “Longaberger Brand”) through its controlling interest in Longaberger Licensing, LLC. The Company and its licensees distribute through a ubiquitous channel retail sales strategy which includes distribution through interactive television, the Internet and e-commerce, and traditional brick-and-mortar retail channels. Headquartered in New York City, Xcel is led by an executive team with significant production, merchandising, design, marketing, retailing, and licensing experience, and a proven track record of success in elevating branded consumer product companies. With an experienced team of professionals focused on design, production, and digital marketing, Xcel maintains control of product quality and promotion across all of its product categories and distribution channels.

Our objective is to build a diversified portfolio of lifestyle consumer brands through organic growth and the strategic acquisition of new brands. To grow our brands, we are focused on following primary strategies:

● distribution and/or licensing of our brands for sale through interactive television (i.e. QVC, The Shopping Channel) whereby we design, manage production, merchandise the shows, and manage the on-air talent;

● licensing our brands to manufacturers and retailers for promotion and distribution through e-commerce, social commerce, and traditional brick-and-mortar retail channels whereby we provide certain design services and, in certain cases, manage supply and merchandising;

● wholesale distribution of our brands to retailers that sell to the end consumer;

● distribution of our brands through our e-commerce sites directly to the end consumer; and

● quickly integrate additional consumer brands into our operating platform and leverage our design, production, and marketing capabilities, and distribution relationships.

We believe that Xcel offers a unique value proposition to our retail and direct-to-consumer customers, and our licensees for the following reasons:

● our management team, including our officers’ and directors’ experience in, and relationships within the industry;

23

● our design, production, sales, marketing, and supply chain and integrated technology platform that enables us to design and distribute trend-right product; and

● our significant media and internet presence and distribution.

We believe that our strategy distinguishes us from other brand management companies that rely primarily on their licensees for design, production, and distribution, and enables us to leverage the media reach of our interactive television partners, including through television, digital, and social media, to drive sales of products under our brands across multiple distribution channels. By leveraging digital and social media content across all distribution channels, we seek to drive consumer engagement and generate retail sales across our brands. Our strong relationships with leading retailers and interactive television companies and cable networks enable us to reach consumers in over 380 million homes worldwide and hundreds of millions of social media followers.

We believe our design, production and supply chain platform provides significant competitive advantages compared with traditional wholesale apparel companies that design, manufacture, and distribute products. We focus on our core competencies of design, integrated technologies, design, production and supply chain platform, marketing, and brand development. We believe that we offer a 360-degree solution to our retail partners that addresses many of the challenges facing the retail industry today. We believe our platform is highly scalable. Additionally, we believe we can quickly integrate additional brands into our platform in order to leverage our design, production, and marketing capabilities, and distribution network.

Summary of Operating Results

Three months ended June 30, 2020 (the “current quarter”) compared with the three months ended June 30, 2019 (the “prior year quarter”)

Revenues

Current quarter net revenue decreased approximately $4.0 million to $5.1 million from $9.1 million for the prior year quarter.

Net licensing revenue decreased by approximately $2.3 million in the current quarter to $4.5 million, compared with $6.8 million in the prior year quarter. This decline was primarily driven by lower sales by our licensees as a result of government-ordered retail store closures as well as an overall slowdown in economic activity related to the COVID-19 pandemic. The decline was also partially attributable, to a lesser extent, to a reduction in guaranteed minimum revenues from one of our existing licensing arrangements upon renewal effective January 1, 2020.

Net product sales decreased by approximately $1.8 million in the current quarter to $0.5 million, compared with $2.3 million in the prior year quarter. Similar to net licensing revenue, the decline in net product sales was primarily driven by lower sales as a result of government-ordered retail store closures as well as an overall slowdown in economic activity related to the COVID-19 pandemic.

Cost of Goods Sold

Current quarter cost of goods sold was $0.3 million, compared with $1.8 million for the prior year quarter due to lower volume of wholesale and e-commerce sales in the current quarter. Gross profit (net revenue less cost of goods sold) decreased approximately $2.7 million to $4.7 million from $7.4 million in the prior year quarter, primarily driven by the aforementioned decline in net licensing revenue.

Total gross profit margin increased from 81% in the prior year quarter to 95% in the current quarter, reflecting the proportional shift of revenue mix towards licensing revenues in the current quarter. Gross profit margin from product sales increased from 24% in the prior year quarter to 54% in the current quarter as a result of achieving greater efficiencies and economies of scale.

24

Operating Costs and Expenses

Operating costs and expenses decreased approximately $1.6 million from $7.0 million in the prior year quarter to $5.4 million in the current quarter. This reduction was primarily due to government assistance received through the Paycheck Protection Program under the CARES Act, for which the Company recognized $1.6 million as a reduction to current quarter expenses. Lower operating costs were also partially attributable to various cost reduction actions taken by management in response to the COVID-19 pandemic, including temporary reductions of employee compensation and cutting non-essential costs. Partially offsetting these decreases in operating costs and expenses was higher depreciation and amortization expense, primarily due to the change in estimated life for the Judith Ripka trademarks. The current quarter also includes $0.5 million of bad debt expense related to the bankruptcy of a large retail customer due to the COVID-19 pandemic. The total allowance of $0.6 million against such customer’s outstanding receivable balance of $1.2 million at June 30, 2020 represents management’s best estimate of collectibility, based on information currently available.

Other Income

During the prior year quarter, we recognized a $2.9 million gain on the reduction of contingent obligations related to the 2015 acquisition of the C Wonder Brand. As part of that acquisition, the seller was eligible to earn additional consideration based on future royalties related to the C Wonder Brand exceeding certain thresholds, and we recorded a liability for the potential future payment of such consideration. The final earn-out period ended on June 30, 2019, and the seller ultimately did not earn any additional consideration under the terms of the purchase agreement.

Interest and Finance Expense

Interest and finance expense for the current quarter was $0.30 million, compared with $0.35 million for the prior year quarter. The decrease from the prior year quarter is primarily attributable to principal payments made on term loan debt, resulting in a lower outstanding principal balance as compared with the prior year quarter.

Income Tax (Benefit) Provision

The effective income tax rate for the current quarter and the prior year quarter was approximately -49% and 37%, respectively, resulting in an income tax provision of $0.43 million and $1.07 million, respectively.

For the current quarter, the federal statutory rate differed from the effective tax rate primarily due to the tax impact from the vesting of restricted shares of common stock, which was treated as a discrete item for tax purposes and decreased the effective rate by approximately 41%. The effective tax rate was also attributable to state taxes and recurring permanent differences, which decreased the effective tax rate by approximately 2% and 27%, respectively. The effective tax rate was also affected by the tax impact of a potential federal net operating loss carryback due to the CARES Act; this item increased the effective rate by approximately 3%.

For the prior year quarter, the federal statutory rate differed from the effective tax rate primarily due to state taxes and recurring permanent differences, which increased the effective tax rate by approximately 9% and 6%, respectively.

Net (Loss) Income

We had a net loss of $(1.34) million for the current quarter, compared with net income of $1.85 million for the prior year quarter.

Non-GAAP Net Income, Non-GAAP Diluted EPS, and Adjusted EBITDA

We had non-GAAP net income of approximately $1.2 million, or $0.06 per diluted share (“non-GAAP diluted EPS”), for the current quarter and $1.0 million, or $0.05 per diluted share, for the prior year quarter. Non-GAAP net income is a non-GAAP unaudited term, which we define as net income (loss), exclusive of amortization of trademarks, stock-based compensation, non-cash interest and finance expense from discounted debt related to acquired assets, loss on extinguishment of debt, gain on reduction of contingent obligations, costs in connection with potential acquisitions, certain

25

adjustments to allowances for doubtful accounts, asset impairments, and deferred income taxes. Non-GAAP net income and non-GAAP diluted EPS measures do not include the tax effect of the aforementioned adjusting items, due to the nature of these items and the Company’s tax strategy. Prior to 2019, the Company did not adjust non-GAAP net income and non-GAAP EPS for the amortization of trademarks or costs in connection with potential acquisitions.

We had Adjusted EBITDA of $1.7 million for the current quarter, compared with Adjusted EBITDA of $1.6 million for the prior year quarter. Adjusted EBITDA is a non-GAAP unaudited measure, which we define as net income (loss) before depreciation and amortization, interest and finance expenses (including loss on extinguishment of debt, if any), income taxes, other state and local franchise taxes, stock-based compensation, gain on reduction of contingent obligations, costs in connection with potential acquisitions, asset impairments, and certain adjustments to allowances for doubtful accounts.

Management uses non-GAAP net income, non-GAAP diluted EPS, and Adjusted EBITDA as measures of operating performance to assist in comparing performance from period to period on a consistent basis and to identify business trends relating to the Company’s results of operations. Management believes non-GAAP net income, non-GAAP diluted EPS, and Adjusted EBITDA are also useful because these measures adjust for certain costs and other events that management believes are not representative of our core business operating results, and thus these non-GAAP measures provide supplemental information to assist investors in evaluating the Company’s financial results. The Company has incurred certain costs which it could have eliminated but elected not to do so in light of government assistance received through the Paycheck Protection Program under the CARES Act (the “PPP Benefit”), which represents a cash benefit directly related to the Company’s operating expenses incurred. Accordingly, the PPP Benefit is not considered a reconciling item for purposes of the computation of non-GAAP net income and Adjusted EBITDA. Adjusted EBITDA is the measure used to calculate compliance with the EBITDA covenant under the Xcel Term Loan.

Non-GAAP net income, non-GAAP diluted EPS, and Adjusted EBITDA should not be considered in isolation or as alternatives to net income, earnings per share, or any other measure of financial performance calculated and presented in accordance with GAAP. Given that non-GAAP net income, non-GAAP diluted EPS, and Adjusted EBITDA are financial measures not deemed to be in accordance with GAAP and are susceptible to varying calculations, our non-GAAP net income, non-GAAP diluted EPS, and Adjusted EBITDA may not be comparable to similarly titled measures of other companies, including companies in our industry, because other companies may calculate non-GAAP net income, non-GAAP diluted EPS, and Adjusted EBITDA in a different manner than we calculate these measures.

In evaluating non-GAAP net income, non-GAAP diluted EPS, and Adjusted EBITDA, you should be aware that in the future we may or may not incur expenses similar to some of the adjustments in this report. Our presentation of non-GAAP net income, non-GAAP diluted EPS, and Adjusted EBITDA does not imply that our future results will be unaffected by these expenses or any unusual or non-recurring items. When evaluating our performance, you should consider non-GAAP net income, non-GAAP diluted EPS, and Adjusted EBITDA alongside other financial performance measures, including our net income and other GAAP results, and not rely on any single financial measure.

The following table is a reconciliation of net (loss) income (our most directly comparable financial measure presented in accordance with GAAP) to non-GAAP net income:

	Three Months Ended
	June 30,
($ in thousands)	2020		2019
Net (loss) income attributable to Xcel Brands, Inc. stockholders	$	(1,300)	$	1,852
Amortization of trademarks		1,108		786
Stock-based compensation		488		135
Costs in connection with potential acquisition		(101)		—
Certain adjustments to allowances for doubtful accounts		472		—
Property and equipment impairment		82		—
Gain on reduction of contingent obligation		—		(2,850)
Deferred income tax provision		428		1,068
Non-GAAP net income	$	1,177	$	991

26

The following table is a reconciliation of diluted (loss) earnings per share (our most directly comparable financial measure presented in accordance with GAAP) to non-GAAP diluted EPS:

	Three Months Ended
	June 30,
	2020		2019
Diluted (loss) earnings per share	$	(0.07)	$	0.10
Amortization of trademarks		0.06		0.04
Stock-based compensation		0.03		0.01
Costs in connection with potential acquisition		(0.01)		—
Certain adjustments to allowances for doubtful accounts		0.02		—
Property and equipment impairment		0.01		—
Gain on reduction of contingent obligation		—		(0.15)
Deferred income tax provision		0.02		0.05
Non-GAAP diluted EPS	$	0.06	$	0.05
Non-GAAP weighted average diluted shares		19,192,353		18,977,051

The following table is a reconciliation of net (loss) income (our most directly comparable financial measure presented in accordance with GAAP) to Adjusted EBITDA:

	Three Months Ended
	June 30,
($ in thousands)	2020		2019
Net (loss) income attributable to Xcel Brands, Inc. stockholders	$	(1,300)	$	1,852
Depreciation and amortization		1,329		1,000
Interest and finance expense		299		348
Income tax provision		428		1,068
State and local franchise taxes		45		83
Stock-based compensation		488		135
Costs in connection with potential acquisition		(101)		—
Certain adjustments to allowances for doubtful accounts		472		—
Property and equipment impairment		82		—
Gain on reduction of contingent obligation		—		(2,850)
Adjusted EBITDA	$	1,742	$	1,636

Both non-GAAP net income and Adjusted EBITDA for the current quarter include certain adjustments to net (loss) income including allowances for doubtful accounts for account debtors that have filed for bankruptcy protection triggered by the impact of COVID-19. In addition, net loss for the current quarter includes $1.6 million of PPP Benefit, which was recognized as a reduction to current quarter expenses for which the program was intended to compensate. As such, this amount is included in net (loss) income in accordance with GAAP. The expense reduction from the PPP is not considered a reconciling item for purposes of the computation of non-GAAP net income and Adjusted EBITDA due to the fact that the PPP Benefit represents a cash benefit and is directly related to the Company’s operating expenses incurred. Such treatment is also consistent with the calculation of EBITDA for financial covenant compliance purposes under the Xcel Term Loan.

Six months ended June 30, 2020 (the “current six months”) compared with the six months ended June 30, 2019 (the “prior year six months”)

Revenues

Current six months net revenue decreased approximately $4.8 million to $14.6 million from $19.4 million for the prior year six months.

27

Net licensing revenue decreased by approximately $4.6 million in the current six months to $10.1 million, compared with $14.7 million in the prior year six months. This decline was primarily driven by a combination of (i) lower customer sales by our licensees as a result of government-ordered retail store closures as well as an overall slowdown in economic activity related to the COVID-19 pandemic, (ii) revenues from one of our existing licensing arrangements changing from guaranteed minimum amounts to sales-based royalties effective April 1, 2019, and (iii) a reduction in guaranteed minimum revenues from another of our existing licensing arrangements upon renewal effective January 1, 2020.

Net product sales decreased by approximately $0.3 million in the current six months to $4.4 million, compared with approximately $4.7 million in the prior year six months. The decline in net product sales was primarily driven by lower sales as a result of government-ordered retail store closures as well as an overall slowdown in economic activity during the related to the COVID-19 pandemic during the second quarter of 2020, partially offset by volume growth in our apparel wholesale business in the first quarter of 2020.

Cost of Goods Sold

Current six months cost of goods sold was $2.7 million, compared with $3.6 million for the prior year six months due to lower overall volume of wholesale and e-commerce sales in the current six months. Gross profit (net revenue less cost of goods sold) decreased approximately $4.0 million to $11.8 million from $15.8 million in the prior year six months, primarily driven by the aforementioned decline in net licensing revenue.

Total gross profit margin was 81% in the prior year six months and 82% in the current six months, essentially flat. Gross profit margin from product sales increased from 25% in the prior year six months to 40% in the current six months as a result of achieving greater efficiencies and economies of scale in our wholesale business operations.

Operating Costs and Expenses

Operating costs and expenses decreased approximately $1.1 million from $14.7 million in the prior year six months to $13.6 million in the current six months. This reduction was primarily due to government assistance received through the Paycheck Protection Program under the CARES Act, for which the Company recognized $1.6 million as a reduction to current six months expenses, as well as various cost reduction actions taken by management in response to the COVID-19 pandemic, including temporary reductions of employee compensation and cutting non-essential costs. Partially offsetting these reductions was higher depreciation and amortization expense, primarily due to the change in estimated life for the Judith Ripka trademarks. The current six months also includes $0.6 million of bad debt expense related to the bankruptcy of a large retail customer due to the COVID-19 pandemic. The total allowance of $0.6 million against such customer’s outstanding receivable balance of $1.2 million at June 30, 2020 represents management’s best estimate of collectibility, based on information currently available.

Other Income

During the prior year six months, we recognized a $2.9 million gain on the reduction of contingent obligations related to the 2015 acquisition of the C Wonder Brand. As part of that acquisition, the seller was eligible to earn additional consideration based on future royalties related to the C Wonder Brand exceeding certain thresholds, and we recorded a liability for the potential future payment of such consideration. The final earn-out period ended on June 30, 2019, and the seller ultimately did not earn any additional consideration under the terms of the purchase agreement.

Interest and Finance Expense

Interest and finance expense for the current six months was $0.59 million, compared with $0.83 million for the prior year six months. This decrease is primarily attributable to the fact that the prior year six months includes a $0.19 million loss on extinguishment of debt as a result of the February 11, 2019 term loan amendment, with no such comparable extinguishment loss in the current six months.

28

Income Tax (Benefit) Provision

The effective income tax rate for the current six months and the prior year six months was approximately 5% and 37%, respectively, resulting in an income tax (benefit) provision of $(0.12) million and $1.14 million, respectively.

For the current six months, the federal statutory rate differed from the effective tax rate primarily due to the tax impact from the vesting of restricted shares of common stock, which was treated as a discrete item for tax purposes and decreased the effect rate by approximately 16%. The effective rate was also attributable to state taxes and recurring permanent differences, which increased the effective tax rate by approximately 5% and decreased the effective tax rate by approximately 8%, respectively. The effective tax rate was also affected by the tax impact of a potential federal net operating loss carryback due to the CARES Act; this item increased the effective rate by approximately 4%.

For the prior year six months, the federal statutory rate differed from the effective tax rate primarily due to state taxes and recurring permanent differences, which increased the effective tax rate by approximately 9% and 6%, respectively.

Net (Loss) Income

We had a net loss of $(2.17) million for the current six months, compared with net income of $1.98 million for the prior year six months.

Non-GAAP Net Income, Non-GAAP Diluted EPS, and Adjusted EBITDA

We had non-GAAP net income of approximately $1.4 million, or $0.07 per diluted share (“non-GAAP diluted EPS”), for the current six months and $2.5 million, or $0.13 per diluted share, for the prior year six months. We had Adjusted EBITDA of $2.5 million for the current six months, compared with Adjusted EBITDA of $3.7 million for the prior year six months.

The following table is a reconciliation of net (loss) income (our most directly comparable financial measure presented in accordance with GAAP) to non-GAAP net income:

	Six Months Ended
	June 30,
($ in thousands)	2020		2019
Net (loss) income attributable to Xcel Brands, Inc. stockholders	$	(2,105)	$	1,979
Amortization of trademarks		2,216		1,523
Non-cash interest and finance expense		—		16
Stock-based compensation		731		482
Loss on extinguishment of debt		—		189
Costs in connection with potential acquisition		(21)		—
Certain adjustments to allowances for doubtful accounts		586		—
Property and equipment impairment		82		—
Gain on reduction of contingent obligation		—		(2,850)
Deferred income tax (benefit) provision		(124)		1,143
Non-GAAP net income	$	1,365	$	2,482

29

The following table is a reconciliation of diluted (loss) earnings per share (our most directly comparable financial measure presented in accordance with GAAP) to non-GAAP diluted EPS:

	Six Months Ended
	June 30,
	2020		2019
Diluted (loss) earnings per share	$	(0.11)	$	0.11
Amortization of trademarks		0.11		0.08
Non-cash interest and finance expense		—		—
Stock-based compensation		0.04		0.02
Loss on extinguishment of debt		—		0.01
Costs in connection with potential acquisition		—		—
Certain adjustments to allowances for doubtful accounts		0.03		—
Property and equipment impairment		0.01		—
Gain on reduction of contingent obligation		—		(0.15)
Deferred income tax (benefit) provision		(0.01)		0.06
Non-GAAP diluted EPS	$	0.07	$	0.13
Non-GAAP weighted average diluted shares		19,001,842		18,771,053

The following table is a reconciliation of net (loss) income (our most directly comparable financial measure presented in accordance with GAAP) to Adjusted EBITDA:

	Six Months Ended
	June 30,
($ in thousands)	2020		2019
Net (loss) income attributable to Xcel Brands, Inc. stockholders	$	(2,105)	$	1,979
Depreciation and amortization		2,632		1,948
Interest and finance expense		593		827
Income tax (benefit) provision		(124)		1,143
State and local franchise taxes		83		121
Stock-based compensation		731		482
Costs in connection with potential acquisition		(21)		—
Certain adjustments to allowances for doubtful accounts		586		—
Property and equipment impairment		82		—
Gain on reduction of contingent obligation		—		(2,850)
Adjusted EBITDA	$	2,457	$	3,650

Both non-GAAP net income and Adjusted EBITDA for the current six months include certain adjustment to net (loss) income including allowances for doubtful accounts for account debtors that have filed for bankruptcy protection triggered by the impact of COVID-19. In addition, net loss for the current six months includes $1.6 million of government assistance received through the Paycheck Protection Program under the CARES Act, which was recognized as a reduction to current six months expenses for which the program was intended to compensate. As such, the PPP Benefit is included in net (loss) income in accordance with GAAP. Such treatment is also consistent with the calculation of EBITDA for financial covenant compliance purposes under the Xcel Term Loan.

Liquidity and Capital Resources

Liquidity

Our principal capital requirements have been to fund working capital needs, acquire new brands, and to a lesser extent, capital expenditures. As of June 30, 2020 and December 31, 2019, our cash and cash equivalents were $5.5 million and $4.6 million, respectively.

30

Restricted cash at June 30, 2020 and at December 31, 2019 consisted of $1.1 million of cash deposited with BHI as collateral for an irrevocable standby letter of credit associated with the lease of our current corporate office and operating facility.

On April 23, 2020, we received $1.8 million from Bank of America through the PPP. We used the proceeds primarily to pay for payroll costs, and we believe it is probable that the loan will be forgiven under the terms of the PPP.

We expect that existing cash and operating cash flows will be adequate to meet our operating needs, term debt service obligations, and capital expenditure needs, for at least the twelve months subsequent to the filing date of this Quarterly Report on Form 10-Q.

Changes in Working Capital

Our working capital (current assets less current liabilities, excluding the current portion of operating lease obligations and any contingent obligations payable in common stock) was $8.5 million and $9.5 million as of June 30, 2020 and December 31, 2019, respectively. Working capital decreased by approximately $1.0 million during the first six months of 2020 primarily due to the increase in the current portion of long-term debt.

Commentary on the components of our cash flows for the current six months as compared with the prior year six months is set forth below.

Operating Activities

Net cash provided by operating activities was approximately $2.38 million in the current six months, compared with approximately $1.98 million in the prior year six months.

The current six months cash provided by operating activities was primarily attributable to the combination of the net loss of $(2.17) million plus non-cash expenses of approximately $4.05 million and the net change in operating assets and liabilities of approximately $0.50 million. The net loss of $(2.17) million includes $1.64 million of government assistance received through the PPP under the CARES Act, which was recognized as a reduction to current six months expenses for which the program was intended to compensate. Non-cash net expenses were primarily comprised of $2.63 million of depreciation and amortization, $0.73 million of stock-based compensation, $0.68 million of bad debt expense, and deferred income tax benefit of $(0.12) million. The net change in operating assets and liabilities includes a decrease in accounts receivable of $3.40 million and a decrease in accounts payable, accrued expenses and other current liabilities of $(2.71) million, and cash paid in excess of rent expense of $(0.18) million. The net change in accounts receivable is attributable to a combination of the timing of collections, and lower revenues recognized as a result of the COVID-19 pandemic. The net change in accounts payable, accrued expenses and other current liabilities is due to timing of payments, as well as actions taken by management in response to the COVID-19 pandemic to conserve cash.

The prior year six months cash provided by operating activities was primarily attributable to the combination of net income of $1.98 million plus non-cash expenses of approximately $0.86 million and net change in operating assets and liabilities of approximately $(0.86) million. Non-cash net expenses primarily consisted of $0.48 million of stock-based compensation, $1.95 million of depreciation and amortization, loss on extinguishment of debt of $0.19 million, deferred income tax provision of $1.14 million, and gain on reduction of contingent obligations of $(2.85) million. The net change from operating assets and liabilities included a decrease in accounts receivable of $2.29 million, a decrease in inventory of approximately $1.11 million, an increase in prepaid expenses and other assets of $(0.29) million, a decrease in accounts payable, accrued expenses and other current liabilities of $(3.54) million, and a decrease in other liabilities of $(0.20) million, all of which are primarily due to timing of collections and payments, and cash paid in excess of rent expense of $(0.24) million.

Investing Activities

Net cash used in investing activities for the current six months was approximately $0.63 million, compared with approximately $9.4 million in the prior year six months. Cash used in investing activities for in the current six months was

31

primarily attributable to capital expenditures, a substantial portion of which relates to the implementation of our ERP system, while cash used in investing activities for the prior year six months was primarily related to cash consideration paid to acquire the Halston Heritage Brands.

Financing Activities

Net cash used in financing activities for the current six months was approximately $(0.93) million, and was primarily attributable to payments made on long-term debt obligations of $(0.75) million, and $(0.19) million of shares repurchased related to vested restricted stock in exchange for withholding taxes.

Net cash provided by financing activities for the prior year six months was approximately $4.5 million, primarily attributable to proceeds received from long-term debt of $7.5 million, partially offset by payments made on long-term debt obligations of $(2.74) million, and payment of $(0.29) million of deferred finance costs.

Other Factors

We continue to seek to expand and diversify the types of licensed products being produced under our brands. We plan to continue to diversify the distribution channels within which licensed products are sold, in an effort to reduce dependence on any particular retailer, consumer, or market sector within each of our brands. The Mizrahi brand, Halston brand, and C Wonder brand have a core business in fashion apparel and accessories. The Ripka brand is a fine jewelry business, and the Longaberger brand focuses on home good products, which we believe helps diversify our industry focus while at the same time complements our business operations and relationships.

We have transitioned our department store business from a licensing model to a wholesale model, and continue to work towards expanding our Judith Ripka Fine Jewelry wholesale and e-commerce business. Our strategy is to manage our working capital needs by utilizing back-to-back sales and purchase orders and minimizing inventory risk. This change should, on a long-term basis, increase our revenues as compared to the licensing model. We expect to develop a core licensing business for the Longaberger brand, in addition to a direct-to-consumer business.

In addition, we continue to seek new opportunities, including expansion through interactive television, our design, production and supply chain platform, additional domestic and international licensing arrangements, and acquiring additional brands.

However, the impacts of the current COVID-19 pandemic are broad reaching and are having an impact on our licensing and wholesale businesses. The COVID-19 pandemic is impacting our supply chain as most of our products are manufactured in China, Thailand, and other places around the world affected by this event. Temporary factory closures and the pace of workers returning to work have impacted our contract manufacturers’ ability to source certain raw materials and to produce finished goods in a timely manner. The pandemic is also impacting distribution and logistics providers' ability to operate in the normal course of business. In addition, COVID-19 has resulted in a sudden and continuing decrease in sales for many of our products, resulting in order cancellations. Further, the pandemic has affected the financial health of certain of our customers, and the bankruptcy of certain other customers, including Lord & Taylor and Le Tote, from which we had an aggregate of $1,172,000 of accounts receivable due at June 30, 2020. As a result, we have recognized an allowance for doubtful accounts of $586,000 for the six months ended June 30, 2020, and may be required to make additional adjustments for doubtful accounts which would increase our operating expenses in future periods and negatively impact our operating results, and could result in our failure to meet financial covenants under our credit facility. Financial impacts associated with the COVID-19 pandemic include, but are not limited to, lower net sales, adjustments to allowances for doubtful accounts due to customer bankruptcy or other inability to pay their amounts due to vendors, the delay of inventory production and fulfillment, potentially further impacting net sales, and potential incremental costs associated with mitigating the effects of the pandemic, including increased freight and logistics costs and other expenses. The impact of the COVID-19 pandemic is expected to continue to have an adverse effect on our operating results, which could result in our inability to comply with certain debt covenants and require BHI to waive compliance with, or agree to amend, any such covenant to avoid a default. The COVID-19 pandemic is ongoing, and its dynamic nature, including uncertainties relating to the ultimate geographic spread of the virus, the severity of the disease, the duration of the pandemic, and actions that would be taken by governmental authorities to contain the pandemic or to treat its impact, makes it difficult to forecast

32

any effects on our results for the remainder of 2020. However, as of the date of this filing, we expect our results for 2020 and potentially 2021 to be significantly affected.

Effects of Inflation

We do not believe that the relatively moderate rates of inflation experienced over the past two years in the United States, where we primarily compete, have had a significant effect on revenues or profitability. If there were an adverse change in the rate of inflation by less than 10%, the expected effect on net income and cash flows would be immaterial.

Off-Balance Sheet Arrangements

We do not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future material effect on our financial condition, results of operations, or liquidity.

Critical Accounting Policies

The preparation of our unaudited condensed consolidated financial statements in conformity with GAAP requires management to exercise judgment. We exercise considerable judgment with respect to establishing sound accounting policies and in making estimates and assumptions that affect the reported amounts of our assets and liabilities, our recognition of revenues and expenses, and disclosure of commitments and contingencies at the date of the financial statements. We evaluate our estimates and judgments on an on-going basis. We base our estimates and judgments on a variety of factors, including our historical experience, knowledge of our business and industry, and current and expected economic conditions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. We periodically re-evaluate our estimates and assumptions with respect to these judgments and modify our approach when circumstances indicate that modifications are necessary. While we believe that the factors we evaluate provide us with a meaningful basis for establishing and applying sound accounting policies, we cannot guarantee that the results will always be accurate. Because the determination of these estimates requires the exercise of judgment, actual results could differ from such estimates.

Please refer to our Annual Report on Form 10-K for the year ended December 31, 2019, filed with the SEC on April 14, 2020, for a discussion of our critical accounting policies. During the three and six months ended June 30, 2020, there were no material changes to our accounting policies.

ITEM 3.    QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Not applicable to smaller reporting companies.

ITEM 4.    CONTROLS AND PROCEDURES

A. EVALUATION OF DISCLOSURE CONTROLS AND PROCEDURES:

Our management, under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) as of June 30, 2020, the end of the period covered by this report. Based on, and as of the date of such evaluation, the Chief Executive Officer and the Chief Financial Officer have concluded that our disclosure controls and procedures were effective as of June 30, 2020 such that the information required to be disclosed in our SEC reports is recorded, processed, summarized, and reported within the time periods specified in SEC rules and forms, and is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosure.

33

B. CHANGES IN INTERNAL CONTROL OVER FINANCIAL REPORTING:

There have not been any significant changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the fiscal quarter ended June 30, 2020 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II. OTHER INFORMATION

ITEM 1.    LEGAL PROCEEDINGS

In the ordinary course of business, from time to time we become involved in legal claims and litigation. In the opinion of management, based on consultations with legal counsel, the disposition of litigation currently pending against us is unlikely to have, individually or in the aggregate, a materially adverse effect on our business, financial position, or results of operations.

ITEM 1A.    RISK FACTORS

In addition to the Risk Factors set forth in Part I, Item 1A, “Risk Factors” of our Annual Report on Form 10-K for the year ended December 31, 2019, set forth below are certain factors which could affect our financial condition and operating results. We operate in a highly competitive industry that involves numerous known and unknown risks and uncertainties that could impact our operations. The risks described in Part I, Item 1A, “Risk Factors” of our Annual Report on Form 10-K for the year ended December 31, 2019 are not the only risks we face. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our financial condition and/or operating results.

Our failure to meet the continued listing requirements of the Nasdaq Global Market could result in a delisting of our common stock, which could negatively impact the market price and liquidity of our common stock and our ability to access the capital markets.

On August 6, 2020, we, received a letter from the Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) notifying us that the minimum bid price per share for our common stock fell below $1.00 for a period of 30 consecutive business days. Therefore, the Company did not meet the minimum bid price requirement set forth in the Nasdaq Listing Rules.

The letter also states that pursuant to Nasdaq Listing Rules 5810(c)(3)(A), we will be provided 180 calendar days to regain compliance with the minimum bid price requirement, or until February 2, 2021.

We can regain compliance if, at any time during the Tolling Period or such 180-day period, the closing bid price of our common stock is at least $1.00 for a minimum period of 10 consecutive business days. If by February 2, 2021, we do not regain compliance with the Nasdaq Listing Rules, we may be eligible for additional time to regain compliance pursuant to Nasdaq Listing Rule 5810(c)(3)(A)(ii). To qualify, we would need to submit a transfer application and a $5,000 application fee. We would also need to provide written notice to Nasdaq of our intention to cure the minimum bid price deficiency during the second compliance period by effecting a reverse stock split, if necessary. As part of its review process, the Nasdaq staff will make a determination of whether it believes we will be able to cure this deficiency. Should the Nasdaq staff conclude that we will not be able to cure the deficiency, or should we determine not to submit a transfer application or make the required representation, Nasdaq will provide notice that our shares of common stock will be subject to delisting.

If we do not regain compliance within the allotted compliance period, including any extensions that may be granted by Nasdaq, Nasdaq will provide notice that our shares of common stock will be subject to delisting from the Nasdaq Global Select Market. At such time, we may appeal the delisting determination to a hearings panel.

We intend to monitor our common stock closing bid price between now and February 2, 2021, and will consider available options to resolve the Company’s noncompliance with the minimum bid price requirement, as may be necessary. There

34

can be no assurance that the Company will be able to regain compliance with the minimum bid price requirement or will otherwise be in compliance with other Nasdaq listing criteria.

The COVID-19 pandemic is having a material adverse impact on our business, operating results, and financial condition.

A pandemic or outbreak of disease or similar public health threat, such as the COVID-19 pandemic, or fear of such an event, could have a material adverse impact on our business, operating results, and financial condition. The current COVID-19 pandemic has caused a disruption to our business, beginning in March 2020. The impacts of the current COVID-19 pandemic are broad reaching and are having an impact on our licensing and wholesale businesses. The COVID-19 pandemic is impacting our supply chain as most of our products are manufactured in China, Thailand, and other places around the world affected by this event. Temporary factory closures and the pace of workers returning to work have impacted our contract manufacturers’ ability to source certain raw materials and to produce finished goods in a timely manner. The pandemic is also impacting distribution and logistics providers' ability to operate in the normal course of business. In addition, COVID-19 has resulted in a sudden and continuing decrease in sales for many of our products, resulting in order cancellations. Further, the pandemic has affected the financial health of certain of our customers, and the bankruptcy of certain other customers, including Lord & Taylor and Le Tote, from which we had an aggregate of $1,172,000 of accounts receivable due at June 30, 2020. As a result, we have recognized an allowance for doubtful accounts of $586,000 for the six months ended June 30, 2020, and may be required to make additional adjustments for doubtful accounts which would increase our operating expenses in future periods and negatively impact our operating results, and could result in our failure to meet financial covenants under our credit facility. Financial impacts associated with the COVID-19 pandemic include, but are not limited to, lower net sales, adjustments to allowances for doubtful accounts due to customer bankruptcy or other inability to pay their amounts due to vendors, the delay of inventory production and fulfillment, potentially further impacting net sales, and potential incremental costs associated with mitigating the effects of the pandemic, including increased freight and logistics costs and other expenses. We expect that the impact the COVID-19 pandemic may have on our operating results could result in our inability to comply with certain debt covenants and require BHI to waive compliance with, or agree to amend, any such covenant to avoid a default. The COVID-19 pandemic is ongoing, and its dynamic nature, including uncertainties relating to the ultimate geographic spread of the virus, the severity of the disease, the duration of the pandemic, and actions that would be taken by governmental authorities to contain the pandemic or to treat its impact, makes it difficult to forecast any effects on our 2020 results. However, as of the date of this filing, we expect our results for 2020 and potentially 2021 to be significantly affected.

We may not be entitled to forgiveness of our recently received Paycheck Protection Program loan, and our application for the Paycheck Protection Program loan could in the future be determined to have been impermissible or could result in damage to our reputation.

We received an unsecured loan in the amount of $1,805,856 (the “PPP Loan”) pursuant to the Paycheck Protection Program (the “PPP”) under the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”). The PPP Loan has a two-year term and bears interest at a rate of 1.0% per annum. Monthly principal and interest payments are deferred for six months after the date of disbursement. The PPP Loan may be prepaid at any time prior to maturity with no prepayment penalties. The Promissory Note contains events of default and other provisions customary for a loan of this type. The Paycheck Protection Program provides that the PPP Loan may be partially or wholly forgiven if the funds are used for certain qualifying expenses as described in the CARES Act. Such forgiveness will be determined, subject to limitations, based on the use of loan proceeds for payment of payroll costs and any payments of mortgage interest, rent, and utilities. However, no assurance is provided that forgiveness for any portion of the PPP Loan will be obtained.

In order to apply for the PPP Loan, we were required to certify, among other things, that the current economic uncertainty made the PPP Loan request necessary to support our ongoing operations. We made this certification in good faith after analyzing, among other things, our financial situation and access to alternative forms of capital, and believe that we satisfied all eligibility criteria for the PPP Loan, and that our receipt of the PPP Loan is consistent with the broad objectives of the PPP of the CARES Act. The certification described above did not contain any objective criteria and is subject to interpretation. However, on April 23, 2020, the U.S. Small Business Administration (“SBA”) issued guidance stating that it is unlikely that a public company with substantial market value and access to capital markets will be able to make the required certification in good faith. The lack of clarity regarding loan eligibility under the PPP has resulted in significant

35

media coverage and controversy with respect to public companies applying for and receiving loans. If, despite our good-faith belief that we satisfied all eligible requirements for the PPP Loan, we or any company that we may acquire in the future which received a loan under the PPP, are later determined to have violated any of the laws or governmental regulations that apply to us or such acquiree in connection with the PPP Loan or another loan under the PPP, respectively, such as the False Claims Act, or it is otherwise determined that we or such acquiree were ineligible to receive the PPP Loan or such other loan under the PPP, respectively, we or such acquiree may be subject to penalties, including significant civil, criminal and administrative penalties, and could be required to repay the PPP Loan or such other loan under the PPP, respectively, in its entirety. In addition, our receipt of the PPP Loan or any company that we may acquire in the future which received a loan under the PPP may result in adverse publicity and damage to our reputation, and a review or audit by the SBA or other government entity or claims under the False Claims Act could consume significant financial and management resources.

ITEM 2.    UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

There were no sales of unregistered or registered securities during the three and six months ended June 30, 2020.

ITEM 3.    DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4.    MINE SAFETY DISCLOSURES

Not applicable.

ITEM 5.    OTHER INFORMATION

None.

ITEM 6.    EXHIBITS

The following exhibits are filed herewith:

31.1 Rule 13a-14(a)/15d-14(a) Certification (CEO)

31.2 Rule 13a-14(a)/15d-14(a) Certification (CFO)

32.1 Section 1350 Certification (CEO)

32.2 Section 1350 Certification (CFO)

101.INS XBRL Instance Document

101.SCH XBRL Taxonomy Extension Schema Document

101.CAL XBRL Taxonomy Extension Calculation Linkbase Document

101.DEF XBRL Taxonomy Extension Definitions Linkbase Document

101.LAB XBRL Taxonomy Extension Label Linkbase Document

101.PRE XBRL Taxonomy Extension Presentation Linkbase Document

36

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: August 19, 2020	By:	/s/ Robert W. D’Loren
		Name: Robert W. D’Loren
		Title: Chairman and Chief Executive Officer
	By:	/s/ James Haran
		Name: James Haran
		Title: Chief Financial Officer and Vice President

37

EX-31.1

EXHIBIT 31.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Robert W. D’Loren, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q for the quarter ended June 30, 2020 of Xcel Brands, Inc. (the “Company”).

2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report;

3. Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

August 19, 2020	By:	/s/ Robert W. D’Loren
		Name: Robert W. D’Loren
		Title: Chairman and Chief Executive Officer

EX-31.2

EXHIBIT 31.2

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, James Haran, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q for the quarter ended June 30, 2020 of Xcel Brands, Inc. (the “Company”).

2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report;

3. Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the Company’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

August 19, 2020	By:	/s/ James Haran
		Name: James Haran
		Title: Chief Financial Officer and Vice
		President

EX-32.1

EXHIBIT 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Xcel Brands, Inc. (the “Company”) on Form 10-Q for the period ended June 30, 2020 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Robert W. D’Loren, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

May
August 19, 2020	By:	/s/ Robert W. D’Loren
		Name: Robert W. D’Loren
		Title: Chairman and Chief Executive Officer

EX-32.2

EXHIBIT 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Xcel Brands, Inc. (the “Company”) on Form 10-Q for the period ended June 30, 2020 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, James Haran, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

August 19, 2020	By:	/s/ James Haran
		Name: James Haran
		Title: Chief Financial Officer and Vice President

XML

Document and Entity Information - shares	6 Months Ended
	Jun. 30, 2020	Aug. 07, 2020
Document And Entity Information [Abstract]
Document Type	10-Q
Document Period End Date	Jun. 30, 2020
Entity Registrant Name	XCel Brands, Inc.
Entity Filer Category	Non-accelerated Filer
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		19,231,040
Amendment Flag	false
Entity Central Index Key	0001083220
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	Q2
Current Fiscal Year End Date	--12-31

XML

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Jun. 30, 2020	Dec. 31, 2019
Current Assets:
Cash and cash equivalents	$ 5,461	$ 4,641
Accounts receivable, net	6,543	10,622
Inventory	866	899
Prepaid expenses and other current assets	1,775	1,404
Total current assets	14,645	17,566
Property and equipment, net	3,866	3,666
Operating lease right-of-use assets	8,569	9,250
Trademarks and other intangibles, net	108,815	111,095
Restricted cash	1,109	1,109
Other assets	494	505
Total non-current assets	122,853	125,625
Total Assets	137,498	143,191
Current Liabilities:
Accounts payable, accrued expenses and other current liabilities	2,722	4,391
Accrued payroll	527	1,444
Current portion of operating lease obligation	1,873	1,752
Current portion of long-term debt	2,900	2,250
Total current liabilities	8,022	9,837
Long-Term Liabilities:
Long-term portion of operating lease obligation	8,789	9,773
Long-term debt, less current portion	15,231	16,571
Contingent obligation	900	900
Deferred tax liabilities, net	7,310	7,434
Other long-term liabilities	224	224
Total long-term liabilities	32,454	34,902
Total Liabilities	40,476	44,739
Commitments and Contingencies
Equity:
Preferred stock, $.001 par value, 1,000,000 shares authorized, none issued and outstanding	0	0
Common stock, $.001 par value, 50,000,000 shares authorized, and 19,231,040 and 18,866,417 shares issued and outstanding at June 30, 2020 and December 31, 2019, respectively	19	19
Paid-in capital	102,180	101,736
Accumulated deficit	(5,764)	(3,659)
Total Xcel Brands, Inc. stockholders' equity	96,435	98,096
Noncontrolling interest	587	356
Total Equity	97,022	98,452
Total Liabilities and Equity	$ 137,498	$ 143,191

XML

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Jun. 30, 2020	Dec. 31, 2019
Statement of Financial Position [Abstract]
Preferred stock, par value (in dollars per share)	$ 0.001	$ 0.001
Preferred stock, shares authorized (in shares)	1,000,000	1,000,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, shares authorized (in shares)	50,000,000	50,000,000
Common stock, shares issued (in shares)	19,231,040	18,866,417
Common stock, shares outstanding (in shares)	19,231,040	18,866,417

XML

Condensed Consolidated Statements of Operations - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Revenues
Net revenue	$ 5,050	$ 9,138	$ 14,577	$ 19,439
Cost of goods sold (sales)	253	1,767	2,653	3,599
Gross profit	4,797	7,371	11,924	15,840
Operating costs and expenses
Salaries, benefits and employment taxes	2,882	3,848	6,830	7,993
Other design and marketing costs	638	797	1,630	1,555
Other selling, general and administrative expenses	1,627	1,173	3,364	2,763
Stock-based compensation	488	135	731	482
Depreciation and amortization	1,329	1,000	2,632	1,948
Government assistance - Paycheck Protection Program	(1,640)		(1,640)
Property and equipment impairment	82		82
Total operating costs and expenses	5,406	6,953	13,629	14,741
Other Income
Gain on reduction of contingent obligation		2,850		2,850
Total other income		2,850		2,850
Operating (loss) income	(609)	3,268	(1,705)	3,949
Interest and finance expense
Interest expense and other finance charges	299	348	593	638
Loss on extinguishment of debt	0	0	0	189
Total interest and finance expense	299	348	593	827
(Loss) income before income taxes	(908)	2,920	(2,298)	3,122
Income tax provision (benefit)	428	1,068	(124)	1,143
Net (loss) income	(1,336)	1,852	(2,174)	1,979
Less: Net loss attributable to noncontrolling interest	(36)		(69)
Net (loss) income attributable to Xcel Brands, Inc. stockholders	$ (1,300)	$ 1,852	$ (2,105)	$ 1,979
(Loss) earnings per share attributable to Xcel Brands, Inc. common stockholders:
Basic net (loss) income per share:	$ (0.07)	$ 0.10	$ (0.11)	$ 0.11
Diluted net (loss) income per share:	$ (0.07)	$ 0.10	$ (0.11)	$ 0.11
Weighted average number of common shares outstanding:
Basic weighted average common shares outstanding	19,132,244	18,976,394	19,001,321	18,770,378
Diluted weighted average common shares outstanding	19,132,244	18,977,051	19,001,321	18,771,053
Net licensing revenue [Member]
Revenues
Net revenue	$ 4,501	$ 6,803	$ 10,142	$ 14,666
Net sales revenue [Member]
Revenues
Net revenue	$ 549	$ 2,335	$ 4,435	$ 4,773

XML

Condensed Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Common Stock	Paid-In Capital [Member]	Retained Earnings (Accumulated Deficit) [Member]	Noncontrolling Interest [Member]	Total
Balances at Dec. 31, 2018	$ 18	$ 100,097	$ (233)		$ 99,882
Balances (in shares) at Dec. 31, 2018	18,138,616
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock in connection with the acquisition of Halston Heritage (in shares)	777,778
Issuance of common stock in connection with the acquisition of Halston Heritage	$ 1	1,057			1,058
Compensation expense in connection with stock options and restricted stock		347			347
Net (loss) income			127		127
Balances at Mar. 31, 2019	$ 19	101,501	(106)		101,414
Balances (in shares) at Mar. 31, 2019	18,916,394
Balances at Dec. 31, 2018	$ 18	100,097	(233)		99,882
Balances (in shares) at Dec. 31, 2018	18,138,616
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income					1,979
Balances at Jun. 30, 2019	$ 19	101,636	1,746		103,401
Balances (in shares) at Jun. 30, 2019	18,976,394
Balances at Mar. 31, 2019	$ 19	101,501	(106)		101,414
Balances (in shares) at Mar. 31, 2019	18,916,394
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Compensation expense in connection with stock options and restricted stock		135			135
Shares issued to employees in connection with restricted stock grants (in shares)	60,000
Net (loss) income			1,852		1,852
Balances at Jun. 30, 2019	$ 19	101,636	1,746		103,401
Balances (in shares) at Jun. 30, 2019	18,976,394
Balances at Dec. 31, 2019	$ 19	101,736	(3,659)	$ 356	98,452
Balances (in shares) at Dec. 31, 2019	18,866,417
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Compensation expense in connection with stock options and restricted stock		91			91
Shares issued to executive in connection with stock grants for bonus payments		220			220
Shares issued to executive in connection with stock grants for bonus payments (in shares)	336,700
Shares repurchased from executives and employees in exchange for withholding taxes (in shares)	(155,556)
Shares repurchased from executives and employees in exchange for withholding taxes		(102)			(102)
Net (loss) income			(805)	(33)	(838)
Balances at Mar. 31, 2020	$ 19	101,945	(4,464)	323	97,823
Balances (in shares) at Mar. 31, 2020	19,047,561
Balances at Dec. 31, 2019	$ 19	101,736	(3,659)	356	98,452
Balances (in shares) at Dec. 31, 2019	18,866,417
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Additional investment in Longaberger Licensing, LLC by non-controlling interest					300
Net (loss) income					(2,174)
Balances at Jun. 30, 2020	$ 19	102,180	(5,764)	587	97,022
Balances (in shares) at Jun. 30, 2020	19,231,040
Balances at Mar. 31, 2020	$ 19	101,945	(4,464)	323	97,823
Balances (in shares) at Mar. 31, 2020	19,047,561
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Compensation expense in connection with stock options and restricted stock		55			55
Shares issued to employees in connection with stock grants (in shares)	270,728
Shares issued to employees in connection with stock grants		265			265
Shares repurchased from executives and employees in exchange for withholding taxes (in shares)	(87,249)
Shares repurchased from executives and employees in exchange for withholding taxes		(85)			(85)
Additional investment in Longaberger Licensing, LLC by non-controlling interest				300	300
Net (loss) income			(1,300)	(36)	(1,336)
Balances at Jun. 30, 2020	$ 19	$ 102,180	$ (5,764)	$ 587	$ 97,022
Balances (in shares) at Jun. 30, 2020	19,231,040

XML

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Cash flows from operating activities
Net (loss) income	$ (1,336)	$ 1,852	$ (2,174)	$ 1,979
Adjustments to reconcile net (loss) income to net cash provided by operating activities:
Depreciation and amortization expense	1,329	1,000	2,632	1,948
Property and equipment impairment	82		82
Amortization of deferred finance costs			50	79
Stock-based compensation	488	135	731	482
Amortization of note discount				16
Allowance for doubtful accounts	472	0	683	(144)
Loss on extinguishment of debt	0	0	0	189
Deferred income tax (benefit) provision			(124)	1,143
Gain on reduction of contingent obligation		(2,850)		(2,850)
Changes in operating assets and liabilities:
Accounts receivable			3,396	2,289
Inventory			33	1,113
Prepaid expenses and other assets			(59)	(293)
Accounts payable, accrued expenses and other current liabilities			(2,688)	(3,532)
Cash paid in excess of rent expense			(181)	(244)
Other liabilities				(196)
Net cash provided by operating activities			2,381	1,979
Cash flows from investing activities
Cash consideration for acquisition of Halston Heritage assets			0	(8,830)
Purchase of property and equipment			(634)	(557)
Net cash used in investing activities			(634)	(9,387)
Cash flows from financing activities
Shares repurchased including vested restricted stock in exchange for withholding taxes			(187)
Payment of deferred finance costs			0	(289)
Proceeds from long-term debt			10	7,500
Payment of long-term debt			(750)	(2,742)
Net cash (used in) provided by financing activities			(927)	4,469
Net increase (decrease) in cash, cash equivalents, and restricted cash			820	(2,939)
Cash, cash equivalents, and restricted cash at beginning of period			5,750	10,319
Cash, cash equivalents, and restricted cash at end of period	6,570	7,380	6,570	7,380
Reconciliation to amounts on consolidated balance sheets:
Cash and cash equivalents	5,461	6,271	5,461	6,271
Restricted cash	1,109	1,109	1,109	1,109
Total cash, cash equivalents, and restricted cash	6,570	$ 7,380	6,570	7,380
Supplemental disclosure of non-cash activities:
Operating lease right-of-use asset			0	10,409
Operating lease obligation			0	13,210
Accrued rent offset to operating lease right-of-use assets			0	2,801
Settlement of seller note through offset to receivable				600
Settlement of contingent obligation through offset to note receivable				100
Issuance of common stock in connection with Halston Heritage assets acquisition			0	1,058
Contingent obligation related to acquisition of Halston Heritage assets at fair value			0	900
Liability for equity-based bonuses			100
Amount due from non-controlling interest for capital contribution	$ 300		300
Supplemental disclosure of cash flow information:
Cash paid during the period for income taxes			47	18
Cash paid during the period for interest			$ 811	$ 784

XML

Nature of Operations, Background, and Basis of Presentation

6 Months Ended

Jun. 30, 2020

Nature of Operations, Background, and Basis of Presentation [Abstract]

Nature of Operations, Background, and Basis of Presentation

1. Nature of Operations, Background, and Basis of Presentation

The accompanying condensed consolidated balance sheet as of December 31, 2019 (which has been derived from audited financial statements) and the unaudited interim condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial information and pursuant to the instructions to Form 10‑Q and Article 8 of Regulation S-X promulgated by the United States Securities and Exchange Commission (“SEC”). Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a comprehensive presentation of financial position, results of operations, or cash flows.

In the opinion of management, the accompanying unaudited condensed consolidated financial statements were prepared following the same policies and procedures used in the preparation of the audited consolidated financial statements and reflect all adjustments (consisting of normal recurring adjustments) necessary to present fairly the results of operations, financial position, and cash flows of Xcel Brands, Inc. and its subsidiaries (the “Company” or "Xcel"). The results of operations for the interim periods presented herein are not necessarily indicative of the results for the entire fiscal year or for any future interim periods. These unaudited condensed consolidated financial statements should be read in conjunction with the Company’s Annual Report on Form 10‑K for the year ended December 31, 2019, as filed with the SEC on April 14, 2020.

The Company is a media and consumer products company engaged in the design, production, marketing, wholesale distribution, and direct-to-consumer sales of branded apparel, footwear, accessories, jewelry, home goods and other consumer products, and the acquisition of dynamic consumer lifestyle brands. The Company has developed a design, production, and supply chain capability driven by its proprietary integrated technology platform. Currently, the Company’s brand portfolio consists of the Isaac Mizrahi brands (the "Isaac Mizrahi Brand"), the Judith Ripka brands (the "Ripka Brand"), the Halston brands (the "Halston Brands"), the C Wonder brands (the "C Wonder Brand"), and other proprietary brands. The Company also manages the Longaberger brand (“the Longaberger Brand”) through its 50% ownership interest in Longaberger Licensing, LLC. The Company designs, produces, markets, and distributes products, and in certain cases, licenses its brands to third parties, and generates licensing fees. The Company and its licensees distribute through a ubiquitous-channel retail sales strategy, which includes distribution through interactive television, the internet, and traditional brick-and-mortar retail channels.

Recently Adopted Accounting Pronouncements

The Company adopted Accounting Standards Update ("ASU") No. 2018‑13, “Fair Value Measurement (Topic 820): Disclosure Framework – Changes to the Disclosure Requirements for Fair Value Measurement,” effective January 1, 2020. This ASU adds, modifies, and removes several disclosure requirements relative to the three levels of inputs used to measure fair value in accordance with Topic 820, “Fair Value Measurement.” The adoption of this new guidance did not have any impact on the Company’s results of operations, cash flows, and financial condition.

XML

Trademarks and Other Intangibles

6 Months Ended

Jun. 30, 2020

Goodwill and Intangible Assets Disclosure [Abstract]

Trademarks and Other Intangibles

2. Trademarks and Other Intangibles

Trademarks and other intangibles, net consist of the following:

	Weighted
	Average	June 30, 2020
	Amortization	Gross Carrying		Accumulated		Net Carrying
($ in thousands)	Period	Amount		Amortization		Amount
Trademarks (indefinite-lived)	n/a	$	44,500	$	—	$	44,500
Trademarks (finite-lived)	15 years		34,613		5,714		28,899
Trademarks (finite-lived)	18 years		38,194		3,129		35,065
Other intellectual property	7 years		762		482		280
Copyrights and other intellectual property	10 years		190		119		71
Total		$	118,259	$	9,444	$	108,815

	Weighted
	Average	December 31, 2019
	Amortization	GrossCarrying		Accumulated		Net Carrying
($ in thousands)	Period	Amount		Amortization		Amount
Trademarks (indefinite-lived)	n/a	$	62,900	$	—	$	62,900
Trademarks (finite-lived)	15 years		16,213		4,560		11,653
Trademarks (finite-lived)	18 years		38,194		2,067		36,127
Other intellectual property	7 years		762		428		334
Copyrights and other intellectual property	10 years		190		109		81
Total		$	118,259	$	7,164	$	111,095

Amortization expense for intangible assets was approximately $1.14 million for the three-month period ended June 30, 2020 (the "current quarter") and was approximately $0.83 million for the three-month period ended June 30, 2019 (the "prior year quarter"). Amortization expense for intangible assets was approximately $2.28 million for the six-month period ended June 30, 2020 (the “current six months”) and was approximately $1.60 million for the six-month period ended June 30, 2019 (the “prior year six months”).

Effective January 1, 2020, the Company determined that the Ripka Brand, inclusive of all its trademarks, has a finite life of 15 years, and is amortized on a straight-line basis accordingly. Prior to January 1, 2020, the Ripka Brand trademarks were considered indefinite-lived assets.

The trademarks related to the Isaac Mizrahi Brand have been determined to have indefinite useful lives and, accordingly, no amortization has been recorded for these assets.

XML

Significant Contracts

6 Months Ended

Jun. 30, 2020

Significant Contracts [Abstract]

Significant Contracts

3. Significant Contracts

QVC Agreements

Under the Company’s agreements with QVC, QVC is required to pay the Company fees based primarily on a percentage of its net sales of Isaac Mizrahi, Ripka, and H Halston branded merchandise. QVC royalty revenue represents a significant portion of the Company’s total revenues.

· Total revenues from QVC totaled $4.04 million and $5.94 million for the current and prior year quarter, respectively, representing approximately 81% and 65% of the Company’s total net revenues for the current and prior year quarter, respectively.

· Total revenues from QVC totaled $8.74 million and $12.77 million for the current and prior year six months, respectively, representing approximately 60% and 66% of the Company’s total net revenues for the current and prior year six months, respectively.

· As of June 30, 2020 and December 31, 2019, the Company had receivables from QVC of $3.94 million and $4.33 million, respectively, representing approximately 60% and 41% of the Company’s total receivables, respectively.

XML

Allowance for Doubtful Accounts

6 Months Ended

Jun. 30, 2020

Credit Loss [Abstract]

Allowance for Doubtful Accounts

4. Allowance for Doubtful Accounts

Accounts receivable are presented on the Company’s condensed consolidated balance sheets net of allowances of $793,000 and $155,000 as of June 30, 2020 and December 31, 2019, respectively. The Company recognized bad debt expense of $472,000 and $0 for the current quarter and prior year quarter, respectively, and recognized bad debt expense of $683,000 and $(144,000) for the current six months and prior year six months, respectively.

Included within these amounts, the current quarter and current six months reflect $472,000 and $586,000, respectively, of bad debt expense related to the bankruptcy of a large retail customer due to the novel coronavirus disease pandemic. The total allowance of $586,000 against such customer’s outstanding receivable balance of $1,172,000 million at June 30, 2020 represents management’s best estimate of collectibility, based on information currently available.

XML

Leases

6 Months Ended

Jun. 30, 2020

Leases [Abstract]

Leases

5. Leases

The Company has operating leases for its current office, former office, and certain equipment with a term of 12 months or less. The Company’s office leases have remaining lease terms of approximately 2 years to 8 years.

Under GAAP, a lessee is generally required to recognize a liability for its obligation to make future lease payments (the lease liability) and a right-of-use (“ROU”) asset representing its right to use the underlying leased asset for the lease term. The Company determines if an arrangement is a lease at inception. Operating leases are recorded in operating lease ROU assets, current portion of operating lease liabilities, and long-term operating lease liabilities on the Company’s condensed consolidated balance sheets. The Company does not recognize lease liabilities and ROU assets for lease terms of 12 months or less, but recognizes such lease payments in net income on a straight-line basis over the lease terms.

Operating lease ROU assets and lease liabilities are recognized at commencement date based on the present value of lease payments over the lease term. As most of the Company’s leases do not provide an implicit rate, the Company generally uses its incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. Lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Lease expense for operating lease payments is recognized on a straight-line basis over the lease term.

For the current and prior year quarter, lease expense included in selling, general and administrative expenses on the Company’s unaudited condensed consolidated statements of operations was $0.4 million. For the current and prior year six months, lease expense included in selling, general and administrative expenses on the Company’s unaudited condensed consolidated statements of operations was $0.8 million.

As of June 30, 2020, the weighted average remaining operating lease term was 6.4 years and the weighted average discount rate for operating leases was 6.3%.

Cash paid for amounts included in the measurement of operating lease liabilities was $0.6 million in the prior year quarter, $0.6 million in the current six months, and $1.2 million in the prior year six months. No such cash payments for operating lease liabilities were made during the current quarter, and the $0.6 million amount of such payments due to lessors are recorded as accounts payable in the Company’s unaudited condensed consolidated balance sheet at June 30, 2020. The Company intends to settle or otherwise satisfy such obligations in subsequent periods.

As of June 30, 2020, the maturities of lease liabilities, excluding the aforementioned amounts reflected as accounts payable, were as follows:

($ in thousands)
Remainder of 2020	$	1,212
2021		2,577
2022		1,732
2023		1,552
2024		1,552
After 2024		4,398
Total lease payments		13,023
Less: Discount		2,361
Present value of lease liabilities		10,662
Current portion of lease liabilities		1,873
Non-current portion of lease liabilities	$	8,789

XML

Debt

6 Months Ended

Jun. 30, 2020

Debt Disclosure [Abstract]

Debt

6. Debt

The Company’s net carrying amount of debt was comprised of the following:

	June 30,		December 31,
($ in thousands)	2020		2019
Xcel Term Loan	$	18,250	$	19,000
Unamortized deferred finance costs related to term loan		(129)		(179)
Economic Injury Disaster Loan		10		—
Total		18,131		18,821
Current portion of long-term debt		2,900		2,250
Long-term debt	$	15,231	$	16,571

Xcel Term Loan

On February 11, 2019, the Company entered into an amended loan agreement with Bank Hapoalim B.M. (“BHI”), which amended and restated the prior Xcel Term Loan. Immediately prior to February 11, 2019, the aggregate principal amount of the prior Xcel Term Loan was $14.5 million. Pursuant to the Xcel Term Loan agreement, the Lenders extended to Xcel an additional term loan in the amount of $7.5 million, such that, as of February 11, 2019, the aggregate outstanding balance of all the term loans extended by BHI to Xcel was $22.0 million, which amount was divided under the Xcel Term Loan agreement into two term loans: (1) a term loan in the amount of $7.3 million (“Term Loan A”) and (2) a term loan in the amount of $14.7 million (“Term Loan B” and, together with Term Loan A, the “Term Loans”).

The terms and conditions of the Xcel Term Loan resulted in significantly different debt service payment requirements compared with the prior term debt with BHI. Management assessed and determined that this amendment resulted in a loss on extinguishment of debt and recognized a loss of $0.2 million (consisting of unamortized deferred finance costs) during the prior year quarter. Upon entering into the Xcel Term Loan, Xcel paid an upfront fee in the amount of $0.09 million to BHI.

The Xcel Term Loan also allows that BHI and any other lender party to the Xcel Term Loan (collectively, the “Lenders”) can provide to Xcel a revolving loan facility and a letter of credit facility, the terms of each of which shall be agreed to by Xcel and the Lenders. Amounts advanced under the revolving loan facility (the “Revolving Loans”) will be used for the purpose of consummating acquisitions by Xcel or its subsidiaries that are or become parties to the Xcel Term Loan. Xcel will have the right to convert Revolving Loans to incremental term loans (the “Incremental Term Loans”) in minimum amounts of $5.0 million. The Company has not drawn down any funds under either the revolving loan facility or letter of credit facility.

On April 13, 2020, the Company amended its Second Amended and Restated Loan and Security Agreement with BHI. Under this amendment, the quarterly installment payment due March 31, 2020 was deferred, and the amounts of the quarterly installment payments due throughout the remainder of 2020 were reduced, while the amount of principal to be repaid through variable payments based on excess cash flow was increased. In addition, there were multiple changes and waivers to the various financial covenants. Further, this amendment permitted Xcel to incur unsecured debt through the Paycheck Protection Program (“PPP”) under the Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”), and excludes any associated PPP debt and debt service from the covenant calculations. There were no changes to the total principal balance, interest rate, or maturity date.

On August 18, 2020, the Company further amended its Second Amended and Restated Loan and Security Agreement with BHI. Under this amendment, the amounts of the quarterly installment payments due throughout 2021 were reduced, and the amount of principal to be repaid through variable payments based on excess cash flow was increased.  In addition, there were multiple changes and waivers to the various financial covenants. There were no changes to the total principal balance, interest rate, or maturity date.

The Term Loans mature on December 31, 2023; Incremental Term Loans shall mature on the date set forth in the applicable term note; and Revolving Loans and the letter of credit facility shall mature on such date as agreed upon by Xcel and the Lenders. Any letter of credit issued under Xcel Term Loan shall terminate no later than one year following the date of issuance thereof.

The remaining principal balance of the Xcel Term Loan, as amended, outstanding at June 30, 2020 is payable in fixed installments as set forth in the following table, plus the variable payments as described below:

($ in thousands)
Installment Payment Dates	Amount
September 30, 2020 and December 31, 2020	$	750
March 31, 2021, June 30, 2021, September 30, 2021, and December 31, 2021	$	700
March 31, 2022, June 30, 2022, September 30, 2022, and December 31, 2022	$	1,125
March 31, 2023, June 30, 2023, September 30, 2023, and December 31, 2023	$	1,250

In addition to the fixed installments outlined above, commencing with the fiscal quarter ended March 31, 2021, the Company is required to repay a portion of the Xcel Term Loan in an amount equal to 50% of the excess cash flow for the fiscal quarter, provided that no early termination fee shall be payable with respect to any such payment. Excess cash flow means, for any period, cash flow from operations (before certain permitted distributions) less (i) capital expenditures not made through the incurrence of indebtedness, (ii) all cash principal paid or payable during such period, and (iii) all dividends declared and paid (or which could have been declared and paid) during such period to equity holders of any credit party treated as a disregarded entity for tax purposes. To the extent that the cumulative amount of such variable repayments made is less than $4.45 million as of March 31, 2022, any such shortfall must be repaid at that date.

Thus, the aggregate remaining annual scheduled principal payments under the Xcel Term Loan are as follows:

	Amount of
($ in thousands)	Principal
Year Ending December 31,	Payment
2020	$	1,500
2021		2,800
2022		8,950
2023		5,000
Total	$	18,250

Xcel has the right to prepay the Term Loans, Incremental Term Loans, Revolving Loans, and obligations with respect to letters of credit and accrued and unpaid interest thereon and to terminate the Lenders’ obligations to make Revolving Loans and issue letters of credit; provided that any prepayment of less than all of the outstanding balances of the Term Loans and Incremental Term Loans shall be applied to the remaining amounts due in inverse order of maturity.

If any Term Loan or any Incremental Term Loan is prepaid on or prior to the third anniversary of the Closing Date (including as a result of an event of default), Xcel shall pay an early termination fee as follows: an amount equal to the principal amount of the Term Loan or Incremental Term Loan, as applicable, being prepaid, multiplied by: (i) two percent (2.00%) if any of Term Loan B or any Incremental Term Loan is prepaid on or before the second anniversary of the later of the Closing Date or the date such Incremental Term Loan was made, as applicable; (ii) one percent (1.00%) if any of Term Loan A is prepaid on or before the second anniversary of the Closing Date; (iii) one percent (1.00%) if any of Term Loan B or any Incremental Term Loan is prepaid after the second anniversary of the later of the Closing Date or such Incremental Term Loan was made, as applicable, but on or before the third anniversary of such date; (iv) one-half of one percent (0.50%) if any of Term Loan A is prepaid after the second anniversary of the Closing Date, but on or before the third anniversary of such date; or (v) zero percent (0.00%) if any Term Loan or any Incremental Term Loan is prepaid after the third anniversary of the later of the Closing Date or the date such Incremental Term Loan was made, as applicable.

Notwithstanding the above, Xcel may make a voluntary prepayment of up to $0.75 million without any early termination fees. Any such prepayment would be applied against the April 30, 2021 fixed installment payment and would be excluded from the computation of excess cash flows.

Xcel’s obligations under the Xcel Term Loan are guaranteed by and secured by all of the assets of Xcel and its wholly owned subsidiaries, as well as any subsidiary formed or acquired that becomes a credit party to the Xcel Term Loan agreement (the “Guarantors”) and, subject to certain limitations contained in Xcel Term Loan, equity interests of the Guarantors. Xcel also granted the Lenders a right of first offer to finance any acquisition for which the consideration will be paid other than by cash of Xcel or by the issuance of equity interest of Xcel.

Interest on Term Loan A accrues at a fixed rate of 5.1% per annum and is payable on each day on which the scheduled principal payments on Term Loans are required to be made. Interest on Term Loan B accrues at a fixed rate of 6.25% per annum and is payable on each day on which the scheduled principal payments on Term Loans are required to be made. Interest on the Revolving Loans will accrue at either the Base Rate or LIBOR, as elected by Xcel, plus a margin to be agreed to by Xcel and the Lenders and will be payable on the first day of each month. Base Rate is defined in the Xcel Term Loan agreement as the greater of (a) BHI’s stated prime rate or (b) 2.00% per annum plus the overnight federal funds rate published by the Federal Reserve Bank of New York. Interest on the Incremental Term Loans will accrue at rates to be agreed to by Xcel and the Lenders and will be payable on each day on which the scheduled principal payments under the applicable note are required to be made.

The Xcel Term Loan contains customary covenants, including reporting requirements, trademark preservation, and the following financial covenants of Xcel (on a consolidated basis with Xcel and the Guarantors under the Second Amended and Restated Loan and Security Agreement):

· net worth of at least $90.0 million at the end of each fiscal quarter;

· liquid assets of at least $3.0 million through December 31, 2020, at least $2.5 million for the fiscal quarters ending March 31, 2021 through September 30, 2021,  at least $3.0 million for the fiscal quarter ending December 31, 2021, and at least $5.0 million thereafter;

· EBITDA shall not be less than $5.0 million for the twelve fiscal month period ended March 31, 2020, $4.8 million for the twelve fiscal month period ending June 30, 2020, and $5.0 million for the twelve month fiscal period ending September 30, 2020;  

· the fixed charge coverage ratio for the twelve fiscal month period ending at the end of each fiscal quarter shall not be less than the ratio set forth below:

Fiscal Quarter End	Fixed Charge Coverage Ratio
December 31, 2020, March 31, 2021, June 30, 2021, September 30, 2021, and December 31, 2021	1.25 to 1.00
March 31, 2022, and thereafter	1.10 to 1.00

· capital expenditures (excluding any capitalized compensation costs) shall not exceed $1.6 million for the fiscal year ending December 31, 2020, and $0.7 million for any fiscal year beginning after December 31, 2020; and

· the leverage ratio for the twelve fiscal month period ending at the end of each fiscal period set forth below shall not exceed the ratio below:

Fiscal Period	Maximum Leverage Ratio
June 30, 2020	4.25 to 1.00
September 30, 2020	4.00 to 1.00
December 31, 2020	3.50 to 1.00
March 31, 2021	3.15 to 1.00
June 30, 2021	3.00 to 1.00
September 30, 2021	2.75 to 1.00
December 31, 2021	2.50 to 1.00
March 31, 2022 and each Fiscal Quarter end thereafter	1.50 to 1.00

The Company was in compliance with all applicable covenants as of June 30, 2020.

For the current and prior year quarter, the Company incurred aggregate interest expense related to term loan debt of approximately $285,000 and $326,000, respectively. For the current six months and prior year six months, the Company incurred aggregate interest expense related to term loan debt of approximately $572,000 and $586,000, respectively. The effective interest rate related to term loan debt was approximately 6.6% for the current quarter and current six months, and approximately 6.8% for the prior year quarter and prior year six months.

PPP Loan

On April 20, 2020, the Company executed a promissory note (the “Promissory Note”) with Bank of America, N.A., which provides for an unsecured loan in the amount of $1.806 million (the “PPP Loan”), pursuant to the PPP under the CARES Act. The PPP Loan has a two-year term and bears interest at a fixed rate of 1.0% per annum. Monthly principal and interest payments are deferred for six months after the date of disbursement. The PPP Loan may be prepaid at any time prior to maturity with no prepayment penalties. The Promissory Note contains events of default and other provisions customary for a loan of this type. The PPP Loan was funded on April 23, 2020.

The PPP also provides that the PPP Loan may be partially or wholly forgiven if the funds are used for certain qualifying expenses as described in the CARES Act,  and later amended by the Paycheck Protection Program Flexibility Act (the "Flexibility Act") signed into law on June 5, 2020. Such forgiveness will be determined, subject to limitations, based on the use of loan proceeds for payment of payroll costs and any payments of mortgage interest, rent, and utilities. While management believes that it is probable that the PPP Loan will be forgiven in full, no definite assurance can be provided that forgiveness for any portion of the PPP Loan will be obtained.Management's determination that full forgiveness is probable is based on qualification under the Flexibility Act.

Management evaluated the legal and contractual terms associated with the PPP Loan, and concluded that, although the legal form of the PPP Loan is debt, the PPP Loan represents in substance a government grant that is expected to be forgiven. Given the lack of definitive authoritative guidance under GAAP for accounting for government grants, the Company analogized to accounting guidance under International Accounting Standard 20, “Accounting for Government Grants and Disclosure of Government Assistance.” Under such guidance, once it is probable that the conditions attached to the assistance will be met, the earnings impact of government grants is recorded on a systematic basis over the periods in which the entity recognizes as expenses the related costs for which the grants are intended to compensate. Accordingly, the Company recognized approximately $1,640,000 as a reduction to operating expenses in the current quarter. The remaining amount of $166,000 as of June 30, 2020 is recorded as a deferred credit within accounts payable, accrued expense and other current liabilities in the accompanying condensed consolidated balance sheets, and will be recognized as a reduction to operating expenses in the quarter ending September 30, 2020. No interest expense related to the PPP Loan has been recorded in the Company’s unaudited condensed consolidated financial statements.

Economic Injury Disaster Loan

On May 4, 2020, the Company received a $10,000 loan through the U.S. Small Business Administration’s disaster assistance program. This loan has a thirty-year term and bears interest at a fixed rate of 3.75% per annum.

XML

Stockholders' Equity

6 Months Ended

Jun. 30, 2020

Stockholders' Equity Note [Abstract]

Stockholders' Equity

7.Stockholders’ Equity

2011 Equity Incentive Plan

The Company’s 2011 Equity Incentive Plan, as amended and restated (the “Plan”), is designed and utilized to enable the Company to provide its employees, officers, directors, consultants, and others whose past, present, and/or potential contributions to the Company have been, are, or will be important to the success of the Company, an opportunity to acquire a proprietary interest in the Company. A total of 13,000,000 shares of common stock are eligible for issuance under the Plan. The Plan provides for the grant of any or all of the following types of awards: stock options, restricted stock, deferred stock, stock appreciation rights, and other stock-based awards. The Plan is administered by the Company’s Board of Directors, or, at the Board’s discretion, a committee of the Board.

The Company accounts for stock-based compensation in accordance with ASC Topic 718, “Compensation - Stock Compensation,” by recognizing the fair value of stock-based compensation as an operating expense over the service period of the award or term of the corresponding contract, as applicable.

The fair value of options and warrants is estimated on the date of grant using the Black-Scholes option pricing model. The valuation determined by the Black-Scholes option pricing model is affected by the Company’s stock price as well as assumptions regarding a number of highly complex and subjective variables. These variables include, but are not limited to, expected stock price volatility over the term of the awards, and actual and projected employee stock option exercise behaviors. The risk-free rate is based on the U.S. Treasury rate for the expected life at the time of grant, volatility is based on the average long-term implied volatilities of peer companies, and expected life is based on the estimated average of the life of options and warrants using the simplified method. The Company utilizes the simplified method to determine the expected life of the options and warrants due to insufficient exercise activity during recent years as a basis from which to estimate future exercise patterns. The expected dividend assumption is based on the Company’s history and expectation of dividend payouts.

Restricted stock awards are valued using the fair value of the Company’s stock at the date of grant.

The Company accounts for non-employee awards in accordance with ASU 2018‑07, “Compensation - Stock Compensation (Topic 718) - Improvements to Nonemployee Share-Based Payment Accounting.” Such awards are measured at the grant-date fair value of the equity instruments to be issued, and the Company recognizes compensation cost for grants to non-employees on a straight-line basis over the period of the grant.

For stock option awards for which vesting is contingent upon the achievement of certain performance targets, the timing and amount of compensation expense recognized is based upon the Company’s projections and estimates of the relevant performance metric(s) until the time the performance obligation is satisfied.

Forfeitures are accounted for as a reduction of compensation cost in the period when such forfeitures occur.

Stock Options

Options granted under the Plan expire at various times - either five,  seven, or ten years from the date of grant, depending on the particular grant.

A summary of the Company’s stock options activity for the current six months is as follows:

				Weighted
				Average
		Weighted		Remaining
		Average		Contractual	Aggregate
	Number of	Exercise		Life	Intrinsic
	Options	Price		(in Years)	Value
Outstanding at January 1, 2020	7,222,625	$	3.33	5.82	$	—
Granted	443,500		1.47
Canceled	—		—
Exercised	—		—
Expired/Forfeited	(126,000)		1.81
Outstanding at June 30, 2020, and expected to vest	7,540,125	$	3.32	5.31	$	—
Exercisable at June 30, 2020	2,939,625	$	5.04	1.62	$	—

On January 1, 2020, the Company granted options to purchase 5,000 shares of stock to a board observer. The exercise price of the options is $4.00 per share, and 50% of the options vest on each of January 1, 2021 and January 1, 2022.

On January 31, 2020, the Company granted options to purchase 75,000 shares of stock to a consultant. The exercise price of the options is $1.57 per share, and all options vested immediately on the date of grant.

On February 28, 2020, the Company granted options to purchase 50,000 shares of common stock to an employee. The exercise price is $1.40 per share, and the vesting of such options is dependent upon the Company achieving certain 12-month sales targets through December 31, 2021.

On March 13, 2020, the Company granted options to purchase 50,000 shares of common stock to a certain key employee. The exercise price of the options is $5.50 per share, and all options vested immediately on the date of grant.

On March 31, 2020, the Company granted options to purchase 50,000 shares of common stock to an employee. The exercise price of the options is $0.61 per share, and one-third of the options shall vest on each of March 31, 2021, March 31, 2021, and March 31, 2022.

On April 1, 2020, the Company granted options to purchase an aggregate of 200,000 shares of commons stock to non-management directors. The exercise price of the options is $0.50 per share, and 50% of the options shall vest on each of April 1, 2021 and April 1, 2022.

On April 15, 2020, the Company granted options to purchase 13,500 shares of common stock to a consultant. The exercise price of the options is $3.00 per share. One-third of the options vested on June 30, 2020, and one-third of the options shall vest on each of September 30, 2020 and December 31, 2020.

Compensation expense related to stock options for the current quarter and the prior year quarter was approximately $45,000 and $73,000, respectively. Compensation expense related to stock options for the current six months and prior year six months was approximately $113,000 and $316,000, respectively.

Total unrecognized compensation expense related to unvested stock options at June 30, 2020 amounts to approximately $250,000 and is expected to be recognized over a weighted average period of approximately 1.50 years.

A summary of the Company’s non-vested stock options activity for the current six months is as follows:

		Weighted
		Average
	Number of	Grant Date
	Options	Fair Value
Balance at January 1, 2020	4,551,500	$	0.18
Granted	443,500		0.13
Vested	(279,500)		0.68
Forfeited or Canceled	(115,000)		0.34
Balance at June 30, 2020	4,600,500	$	0.14

Warrants

Warrants expire at various times - either five or ten years from the date of grant, depending on the particular grant.

A summary of the Company’s warrants activity for the current six months is as follows:

				Weighted
				Average
		Weighted		Remaining
		Average		Contractual	Aggregate
	Number of	Exercise		Life	Intrinsic
	Warrants	Price		(in Years)	Value
Outstanding and exercisable at January 1, 2020	579,815	$	4.63	2.32	$	—
Granted	—		—
Canceled	—		—
Exercised	—		—
Expired/Forfeited	—		—
Outstanding and exercisable at June 30, 2020	579,815	$	4.63	1.81	$	—

No compensation expense related to warrants was recognized in the current quarter, current six months, prior year quarter, or prior year six months.

Stock Awards

A summary of the Company’s restricted stock activity for the current six months is as follows:

		Weighted
	Number of	Average
	Restricted	Grant Date
	Shares	Fair Value
Outstanding at January 1, 2020	1,230,623	$	4.33
Granted	607,428		0.80
Canceled	—		—
Vested	(1,057,218)		2.47
Expired/Forfeited	—		—
Outstanding at June 30, 2020	780,833	$	4.09

On March 30, 2020, the Company issued 336,700 shares of stock to a member of senior management as payment for a performance bonus earned in 2019. These shares vested immediately.

On May 20, 2020, the Company issued an aggregate of 270,728 shares of stock to its employees. These shares vested immediately. The Company recognized approximately $265,000 of compensation expense in the current quarter and current six months related to this grant.

Compensation expense related to restricted stock grants for the current and prior year quarter was approximately $10,000 and $104,000, respectively. Compensation expense related to restricted stock grants for the current six months and prior year six months was approximately $33,000 and $166,000, respectively.

Total unrecognized compensation expense related to unvested restricted stock grants at June 30, 2020 amounts to approximately $32,000 and is expected to be recognized over a weighted average period of approximately 0.75 years.

The Company also recognized approximately $168,000 and $320,000 of compensation expense in the current quarter and current six months related to certain senior management bonuses payable in stock in 2021.

Shares Available Under the Company’s 2011 Equity Incentive Plan

As of June 30, 2020, there were 1,218,670 shares of common stock available for issuance under the Plan.

Shares Reserved for Issuance

As of June 30, 2020, there were 9,338,610 shares of common stock reserved for issuance pursuant to unexercised warrants and stock options, or available for issuance under the Plan.

Dividends

The Company has not paid any dividends to date.

XML

Earnings Per Share

6 Months Ended

Jun. 30, 2020

Earnings Per Share [Abstract]

Earnings Per Share

8.Earnings Per Share

Basic earnings per share (“EPS”) is computed by dividing net income (loss) available to common stockholders by the weighted average number of common shares outstanding during the period. Diluted EPS gives effect to all potentially dilutive common shares outstanding during the period, including stock options and warrants, using the treasury stock method. Diluted EPS excludes all potentially dilutive shares of common stock if their effect is anti-dilutive.

	Three Months Ended		Six Months Ended
	June 30,		June 30,
	2020	2019	2020	2019
Basic	19,132,244	18,976,394	19,001,321	18,770,378
Effect of exercise of warrants	—	657	—	675
Diluted	19,132,244	18,977,051	19,001,321	18,771,053

As a result of the net loss presented for the current quarter and current six months, the Company calculated diluted earnings per share using basic weighted average shares outstanding for such period, as utilizing diluted shares would be anti-dilutive to loss per share.

The computation of diluted EPS excludes the following potentially dilutive securities because their inclusion would be anti-dilutive:

	Three Months Ended		Six Months Ended
	June 30,		June 30,
	2020	2019	2020	2019
Stock options and warrants	8,119,940	8,408,386	8,119,940	7,124,005

XML

Income Tax

6 Months Ended

Jun. 30, 2020

Income Tax Disclosure [Abstract]

Income Tax

9.Income Tax

The effective income tax rate for the current quarter and the prior year quarter was approximately -49% and 37%, respectively, resulting in an income tax (benefit) provision of $0.43 million and $1.07 million, respectively.

The effective income tax rate for the current six months and prior year six months was approximately 5% and 37%, respectively, resulting in an income tax (benefit) provision of $(0.12) million and $1.14 million, respectively.

For the current quarter, the federal statutory rate differed from the effective tax rate primarily due to the tax impact from the vesting of restricted shares of common stock, which was treated as a discrete item for tax purposes and decreased the effective rate by approximately 41%. The effective tax rate was also attributable to state taxes and recurring permanent differences, which decreased the effective tax rate by approximately 2% and 27%, respectively. The effective tax rate was also affected by the tax impact of a potential federal net operating loss carryback due to the CARES Act; this item increased the effective rate by approximately 3%.

For the prior year quarter, the federal statutory rate differed from the effective tax rate primarily due to state taxes and recurring permanent differences, which increased the effective tax rate by approximately 9% and 6%, respectively.

For the current six months, the federal statutory rate differed from the effective tax rate primarily due to the tax impact from the vesting of restricted shares of common stock, which was treated as a discrete item for tax purposes and decreased the effect rate by approximately 16%. The effective rate was also attributable to state taxes and recurring permanent differences, which increased the effective tax rate by approximately 5% and decreased the effective tax rate by approximately 8%, respectively. The effective tax rate was also affected by the tax impact of a potential federal net operating loss carryback due to the CARES Act; this item increased the effective rate by approximately 4%.

For the prior year six months, the federal statutory rate differed from the effective tax rate primarily due to state taxes and recurring permanent differences, which increased the effective tax rate by approximately 9% and 6%, respectively.

On March 27, 2020, the CARES Act was enacted and signed into law. The CARES Act includes certain provisions impacting businesses’ income taxes related to 2018, 2019, and 2020. Some of the significant tax law changes are to increase the limitation on deductible business interest expense for 2019 and 2020, allow for the five-year carryback of net operating losses for 2018-2020, suspend the 80% limitation of taxable income for net operating loss carryforwards for 2018-2020, provide for the acceleration of depreciation expense from 2018 and forward on qualified improvement property, and accelerate the ability to claim refunds of AMT credit carryforwards. The Company is required to recognize the effect of tax law changes on its financial statements in the period in which the law was enacted. At this time, the Company may avail itself of the ability to carry back net operating losses generated in 2018 and 2019 tax years for five years, resulting in an estimated income statement benefit of $98,000 and tax refund receivable of $203,000.

XML

Related Party Transactions

6 Months Ended

Jun. 30, 2020

Related Party Transactions [Abstract]

Related Party Transactions

10.Related Party Transactions

Benjamin Malka

Benjamin Malka was a director of the Company from June 2014 through September 2019. Mr. Malka is also a 25% equity holder of House of Halston LLC (“HOH”), and is the former Chief Executive Officer of HOH. HOH is the parent company of the H Company IP, LLC (“HIP”).

On February 11, 2019, the Company and its wholly owned subsidiary, H Heritage Licensing, LLC, entered into an asset purchase agreement (the "Heritage Asset Purchase Agreement") with HIP and HOH, pursuant to which the Company acquired certain assets of HIP, including the "Halston," "Halston Heritage," and "Roy Frowick" trademarks (collectively, the "Halston Heritage Trademarks") and other intellectual property rights relating thereto.

Pursuant to the Heritage Asset Purchase Agreement, at closing, the Company delivered in escrow for HIP or its designees (collectively, the “Sellers”) an aggregate of $8.4 million in cash and 777,778 shares of the Company’s common stock valued at $1.1 million (the “Xcel Shares”), subject to a voting agreement and a lock-up agreement relating to the Xcel Shares and a consent and waiver agreement each in form satisfactory to Xcel within three months from the date of the Heritage Asset Purchase Agreement. Such agreements were executed and delivered to Xcel, and the Xcel Shares were issued and delivered to the Sellers.

In addition to the closing considerations, HIP is eligible to earn up to an aggregate of $6.0 million (the “Earn-Out Value”) through December 31, 2022 based on Excess Net Royalties. “Excess Net Royalties” during any calendar year for 2019 through 2022 (each, a “Royalty Target Year”) is equal to (a) the positive amount, if any, of the Net Royalties as calculated for such Royalty Target Year, less the greater of (i) One Million Five Hundred Thousand Dollars ($1.5 million), or (ii) the maximum Net Royalties for any previous Royalty Target Year. “Applicable Percentage” means (a) 50% of the first $10.0 million of Excess Net Royalties during the Earn-Out Period, (b) 20% of aggregate Excess Net Royalties during the Earn-Out Period greater than $10.0 million and up to $15.0 million and (c) 0% of aggregate Excess Net Royalties during the Earn-Out Period in excess of $15.0 million. The Earn-Out Consideration shall be payable in common stock of Xcel (the “Earn-Out Shares”); provided, however, that if the number of Earn-Out Shares, when combined with the number of Xcel Shares issued at the Closing Date, will exceed 4.99% of the aggregate number of shares of Xcel common stock outstanding as of the Closing Date (calculated in accordance with Nasdaq Rule 5635(a)) (the “Xcel Share Limit”), then Xcel may, in its sole and unfettered discretion, elect to (x) pay cash for the Earn-Out Value attributable to the Earn-Out Shares that would exceed the Xcel Share Limit; (y) solicit stockholder approval for the issuance of Earn-Out Shares in excess of the Xcel Share Limit in accordance with Nasdaq Rule 5635(a)(2) and, if such stockholder approval is obtained, issue such Earn-Out Shares to HIP; or (z) solicit stockholder approval for the issuance of Shares in excess of the Xcel Share Limit in accordance with Nasdaq Rule 5635(a)(2) and, if such stockholder approval is obtained, pay the applicable Earn-Out Consideration with a combination of cash and Earn-Out Shares.

Robert W. D’Loren

Jennifer D’Loren is the wife of Robert W. D’Loren, the Company’s Chief Executive Officer and Chairman of the Board, and is employed by the Company. Mrs. D’Loren brings vast experience in project management and implementation of financial IT solutions. During the past two years, Mrs. D’Loren has worked on the implementation of the Company’s ERP system. Mrs. D’Loren received compensation of $33,000 and $44,000 for the current quarter and prior year quarter, respectively. Mrs. D’Loren received compensation of $70,000 and $83,000 for the current six months and prior year six months, respectively.

XML

Commitments and Contingencies

6 Months Ended

Jun. 30, 2020

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

11.Commitments and Contingencies

Contingent Obligation 

In connection with the February 11, 2019 purchase of the Halston Heritage Trademarks from HIP, the Company agreed to pay HIP additional consideration (the “Halston Heritage Earn-Out”) of up to an aggregate of $6.0 million, based on royalties earned through December 31, 2022. The Halston Heritage Earn-Out of $0.9 million is recorded as a long-term liability at June 30, 2020 and December 31, 2019 in the accompanying condensed consolidated balance sheets, based on the difference between the fair value of the acquired assets of the Halston Heritage Trademarks and the total consideration paid. In accordance with Accounting Standards Codification (“ASC”) Topic 480, “Distinguishing Liabilities from Equity,” the Halston Heritage Earn-Out obligation is treated as a liability in the accompanying condensed consolidated balance sheets because of the variable number of shares payable under the agreement.

Coronavirus Pandemic

In March 2020, the World Health Organization declared the outbreak of a novel coronavirus disease (“COVID-19”) as a pandemic, which continues to spread throughout the U.S. COVID-19 is having an unprecedented impact on the U.S. economy as federal, state, and local governments react to this public health crisis.

The impacts of the current COVID-19 pandemic are broad reaching and are having an impact on the Company’s licensing and wholesale businesses. The COVID-19 pandemic is impacting the Company’s supply chain as most of the Company’s products are manufactured in China, Thailand, and other places around the world affected by this event. Temporary factory closures and the pace of workers returning to work have impacted contract manufacturers’ ability to source certain raw materials and to produce finished goods in a timely manner. The outbreak is also impacting distribution and logistics providers' ability to operate in the normal course of business. Further, the pandemic has resulted in a sudden and continuing decrease in sales for many of the Company’s products, resulting in order cancellations.

Due to the COVID-19 outbreak, there is significant uncertainty surrounding the potential impact on the Company’s future results of operations and cash flows. Continued impacts of the pandemic could materially adversely affect the Company’s near-term and long-term revenues, earnings, liquidity, and cash flows as the Company’s customers and/or licensees may request temporary relief, delay, or not make scheduled payments.

XML

Subsequent Events

6 Months Ended

Jun. 30, 2020

Subsequent Events [Abstract]

Subsequent Events

12.Subsequent Events

On August 6, 2020, the Company entered into an assignment and assumption agreement with the landlord and subtenant at its former office location at 475 Tenth Avenue, New York, NY. Under the terms of this agreement, in exchange for certain consideration totaling approximately $887,000, the landlord agreed to release the Company from all future obligations under the lease effective as of August 1, 2020, and all of the Company’s rights, title, and interest in and to the lease at 475 Tenth Avenue was assigned to the current subtenant in place.

On August 18, 2020, the Company further amended its Second Amended and Restated Loan and Security Agreement with BHI. Under this amendment, the amounts of the quarterly installment payments due throughout 2021 were reduced, and the amount of principal to be repaid through variable payments based on excess cash flow was increased.  In addition, there were multiple changes and waivers to the various financial covenants. There were no changes to the total principal balance, interest rate, or maturity date. See Note 6, “Debt,” for additional information.

XML

Nature of Operations, Background, and Basis of Presentation (Policies)

6 Months Ended

Jun. 30, 2020

Nature of Operations, Background, and Basis of Presentation [Abstract]

Recently Adopted Accounting Pronouncements

Recently Adopted Accounting Pronouncements

The Company adopted Accounting Standards Update ("ASU") No. 2018‑13, “Fair Value Measurement (Topic 820): Disclosure Framework – Changes to the Disclosure Requirements for Fair Value Measurement,” effective January 1, 2020. This ASU adds, modifies, and removes several disclosure requirements relative to the three levels of inputs used to measure fair value in accordance with Topic 820, “Fair Value Measurement.” The adoption of this new guidance did not have any impact on the Company’s results of operations, cash flows, and financial condition.

XML

Trademarks and Other Intangibles (Tables)

6 Months Ended

Jun. 30, 2020

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of Trademarks and Other Intangibles

	Weighted
	Average	June 30, 2020
	Amortization	Gross Carrying		Accumulated		Net Carrying
($ in thousands)	Period	Amount		Amortization		Amount
Trademarks (indefinite-lived)	n/a	$	44,500	$	—	$	44,500
Trademarks (finite-lived)	15 years		34,613		5,714		28,899
Trademarks (finite-lived)	18 years		38,194		3,129		35,065
Other intellectual property	7 years		762		482		280
Copyrights and other intellectual property	10 years		190		119		71
Total		$	118,259	$	9,444	$	108,815

	Weighted
	Average	December 31, 2019
	Amortization	GrossCarrying		Accumulated		Net Carrying
($ in thousands)	Period	Amount		Amortization		Amount
Trademarks (indefinite-lived)	n/a	$	62,900	$	—	$	62,900
Trademarks (finite-lived)	15 years		16,213		4,560		11,653
Trademarks (finite-lived)	18 years		38,194		2,067		36,127
Other intellectual property	7 years		762		428		334
Copyrights and other intellectual property	10 years		190		109		81
Total		$	118,259	$	7,164	$	111,095

XML

Leases (Tables)

6 Months Ended

Jun. 30, 2020

Leases [Abstract]

Maturities of Lease Liabilities

($ in thousands)
Remainder of 2020	$	1,212
2021		2,577
2022		1,732
2023		1,552
2024		1,552
After 2024		4,398
Total lease payments		13,023
Less: Discount		2,361
Present value of lease liabilities		10,662
Current portion of lease liabilities		1,873
Non-current portion of lease liabilities	$	8,789

XML

Debt (Tables)

6 Months Ended

Jun. 30, 2020

Debt Disclosure [Abstract]

Net Carrying Amount of Debt

	June 30,		December 31,
($ in thousands)	2020		2019
Xcel Term Loan	$	18,250	$	19,000
Unamortized deferred finance costs related to term loan		(129)		(179)
Economic Injury Disaster Loan		10		—
Total		18,131		18,821
Current portion of long-term debt		2,900		2,250
Long-term debt	$	15,231	$	16,571

Maturities of Long-term Debt

The remaining principal balance of the Xcel Term Loan, as amended, outstanding at June 30, 2020 is payable in fixed installments as set forth in the following table, plus the variable payments as described below:

($ in thousands)
Installment Payment Dates	Amount
September 30, 2020 and December 31, 2020	$	750
March 31, 2021, June 30, 2021, September 30, 2021, and December 31, 2021	$	700
March 31, 2022, June 30, 2022, September 30, 2022, and December 31, 2022	$	1,125
March 31, 2023, June 30, 2023, September 30, 2023, and December 31, 2023	$	1,250

In addition to the fixed installments outlined above, commencing with the fiscal quarter ended March 31, 2021, the Company is required to repay a portion of the Xcel Term Loan in an amount equal to 50% of the excess cash flow for the fiscal quarter, provided that no early termination fee shall be payable with respect to any such payment. Excess cash flow means, for any period, cash flow from operations (before certain permitted distributions) less (i) capital expenditures not made through the incurrence of indebtedness, (ii) all cash principal paid or payable during such period, and (iii) all dividends declared and paid (or which could have been declared and paid) during such period to equity holders of any credit party treated as a disregarded entity for tax purposes. To the extent that the cumulative amount of such variable repayments made is less than $4.45 million as of March 31, 2022, any such shortfall must be repaid at that date.

Thus, the aggregate remaining annual scheduled principal payments under the Xcel Term Loan are as follows:

	Amount of
($ in thousands)	Principal
Year Ending December 31,	Payment
2020	$	1,500
2021		2,800
2022		8,950
2023		5,000
Total	$	18,250

Schedule of Fixed Charge Coverage Ratios and Leverage Ratios

The Xcel Term Loan contains customary covenants, including reporting requirements, trademark preservation, and the following financial covenants of Xcel (on a consolidated basis with Xcel and the Guarantors under the Second Amended and Restated Loan and Security Agreement):

· net worth of at least $90.0 million at the end of each fiscal quarter;

· liquid assets of at least $3.0 million through December 31, 2020, at least $2.5 million for the fiscal quarters ending March 31, 2021 through September 30, 2021,  at least $3.0 million for the fiscal quarter ending December 31, 2021, and at least $5.0 million thereafter;

· EBITDA shall not be less than $5.0 million for the twelve fiscal month period ended March 31, 2020, $4.8 million for the twelve fiscal month period ending June 30, 2020, and $5.0 million for the twelve month fiscal period ending September 30, 2020;  

· the fixed charge coverage ratio for the twelve fiscal month period ending at the end of each fiscal quarter shall not be less than the ratio set forth below:

Fiscal Quarter End	Fixed Charge Coverage Ratio
December 31, 2020, March 31, 2021, June 30, 2021, September 30, 2021, and December 31, 2021	1.25 to 1.00
March 31, 2022, and thereafter	1.10 to 1.00

· capital expenditures (excluding any capitalized compensation costs) shall not exceed $1.6 million for the fiscal year ending December 31, 2020, and $0.7 million for any fiscal year beginning after December 31, 2020; and

· the leverage ratio for the twelve fiscal month period ending at the end of each fiscal period set forth below shall not exceed the ratio below:

Fiscal Period	Maximum Leverage Ratio
June 30, 2020	4.25 to 1.00
September 30, 2020	4.00 to 1.00
December 31, 2020	3.50 to 1.00
March 31, 2021	3.15 to 1.00
June 30, 2021	3.00 to 1.00
September 30, 2021	2.75 to 1.00
December 31, 2021	2.50 to 1.00
March 31, 2022 and each Fiscal Quarter end thereafter	1.50 to 1.00

XML

Stockholders' Equity (Tables)

6 Months Ended

Jun. 30, 2020

Stockholders' Equity Note [Abstract]

Summary of Stock Option Activity

				Weighted
				Average
		Weighted		Remaining
		Average		Contractual	Aggregate
	Number of	Exercise		Life	Intrinsic
	Options	Price		(in Years)	Value
Outstanding at January 1, 2020	7,222,625	$	3.33	5.82	$	—
Granted	443,500		1.47
Canceled	—		—
Exercised	—		—
Expired/Forfeited	(126,000)		1.81
Outstanding at June 30, 2020, and expected to vest	7,540,125	$	3.32	5.31	$	—
Exercisable at June 30, 2020	2,939,625	$	5.04	1.62	$	—

Summary of Stock Option Activity for Non-Vested Options

		Weighted
		Average
	Number of	Grant Date
	Options	Fair Value
Balance at January 1, 2020	4,551,500	$	0.18
Granted	443,500		0.13
Vested	(279,500)		0.68
Forfeited or Canceled	(115,000)		0.34
Balance at June 30, 2020	4,600,500	$	0.14

Summary of Warrants Activity

				Weighted
				Average
		Weighted		Remaining
		Average		Contractual	Aggregate
	Number of	Exercise		Life	Intrinsic
	Warrants	Price		(in Years)	Value
Outstanding and exercisable at January 1, 2020	579,815	$	4.63	2.32	$	—
Granted	—		—
Canceled	—		—
Exercised	—		—
Expired/Forfeited	—		—
Outstanding and exercisable at June 30, 2020	579,815	$	4.63	1.81	$	—

Summary of Restricted Stock Activity

		Weighted
	Number of	Average
	Restricted	Grant Date
	Shares	Fair Value
Outstanding at January 1, 2020	1,230,623	$	4.33
Granted	607,428		0.80
Canceled	—		—
Vested	(1,057,218)		2.47
Expired/Forfeited	—		—
Outstanding at June 30, 2020	780,833	$	4.09

XML

Earnings Per Share (Tables)

6 Months Ended

Jun. 30, 2020

Earnings Per Share [Abstract]

Computation of Diluted Earnings Per Share

	Three Months Ended		Six Months Ended
	June 30,		June 30,
	2020	2019	2020	2019
Basic	19,132,244	18,976,394	19,001,321	18,770,378
Effect of exercise of warrants	—	657	—	675
Diluted	19,132,244	18,977,051	19,001,321	18,771,053

Anti-dilutive Securities Excluded from Computation of Earnings Per Share

	Three Months Ended		Six Months Ended
	June 30,		June 30,
	2020	2019	2020	2019
Stock options and warrants	8,119,940	8,408,386	8,119,940	7,124,005

XML

Nature of Operations, Background, and Basis of Presentation (Details)	6 Months Ended
	Jun. 30, 2020
Longaberger Licensing, LLC | Variable Interest Entity, Primary Beneficiary
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Variable Interest Entity, Qualitative or Quantitative Information, Ownership Percentage	50.00%

XML

Trademarks and Other Intangibles - Schedule of Assets (Details) - USD ($) $ in Thousands	6 Months Ended	12 Months Ended
	Jun. 30, 2020	Dec. 31, 2019
Trademarks and Other Intangibles
Gross Carrying Amount, Total	$ 118,259	$ 118,259
Accumulated Amortization	9,444	7,164
Net Carrying Amount, Total	$ 108,815	$ 111,095
Trademarks
Trademarks and Other Intangibles
Weighted Average Amortization Period	15 years	15 years
Gross Carrying Amount (definite-lived)	$ 34,613	$ 16,213
Accumulated Amortization	5,714	4,560
Net Carrying Amount	$ 28,899	$ 11,653
Other intellectual property
Trademarks and Other Intangibles
Weighted Average Amortization Period	7 years	7 years
Gross Carrying Amount (definite-lived)	$ 762	$ 762
Accumulated Amortization	482	428
Net Carrying Amount	$ 280	$ 334
Copyrights and other intellectual property
Trademarks and Other Intangibles
Weighted Average Amortization Period	10 years	10 years
Gross Carrying Amount (definite-lived)	$ 190	$ 190
Accumulated Amortization	119	109
Net Carrying Amount	71	81
Trademarks
Trademarks and Other Intangibles
Gross Carrying Amount (indefinite-lived)	$ 44,500	$ 62,900
Halston Heritage | Trademarks
Trademarks and Other Intangibles
Weighted Average Amortization Period	18 years	18 years
Gross Carrying Amount (definite-lived)	$ 38,194	$ 38,194
Accumulated Amortization	3,129	2,067
Net Carrying Amount	$ 35,065	$ 36,127

XML

Trademarks and Other Intangibles - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Goodwill and Intangible Assets [Line Items]
Amortization expense for intangible assets	$ 1,140	$ 830	$ 2,280	$ 1,600
Ripka Brands
Goodwill and Intangible Assets [Line Items]
Finite useful life			15 years

XML

Significant Contracts (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019	Dec. 31, 2019
Product Information [Line Items]
Net revenue	$ 5,050	$ 9,138	$ 14,577	$ 19,439
Accounts receivable, net	6,543		6,543		$ 10,622
Sales [Member] | Customer Concentration Risk [Member] | QVC, Inc. [Member]
Product Information [Line Items]
Net revenue	$ 4,040	$ 5,940	$ 8,740	$ 12,770
Concentration Risk, Percentage	81.00%	65.00%	60.00%	66.00%
Accounts Receivable [Member] | Customer Concentration Risk [Member] | QVC, Inc. [Member]
Product Information [Line Items]
Accounts receivable, net	$ 3,940		$ 3,940		$ 4,330
Concentration Risk, Percentage			60.00%		41.00%

XML

Allowance for Doubtful Accounts (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019	Dec. 31, 2019
Financing Receivable, Allowance for Credit Loss [Line Items]
Allowance for Doubtful Accounts Receivable	$ 793		$ 793		$ 155
Bad debt expense	472	$ 0	683	$ (144)
Accounts receivable, net	6,543		6,543		$ 10,622
Large Retail Customer
Financing Receivable, Allowance for Credit Loss [Line Items]
Bad debt expense	472		586
Accounts receivable, net	$ 1,172		$ 1,172

XML

Leases - Additional Information (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Lessee, Lease, Description [Line Items]
Lease expense included in selling, general and administrative expenses	$ 0.4	$ 0.4	$ 0.8	$ 0.8
Weighted average remaining lease term for operating leases	6 years 4 months 24 days		6 years 4 months 24 days
Weighted average discount rate for operating lease (as percent)	6.30%		6.30%
Cash payments for operating lease expense	$ 0.0	$ 0.6	$ 0.6	$ 1.2
Accounts payable
Lessee, Lease, Description [Line Items]
Cash payments for operating lease expense			$ 0.6
Minimum
Lessee, Lease, Description [Line Items]
Remaining lease term	2 years		2 years
Maximum
Lessee, Lease, Description [Line Items]
Remaining lease term	8 years		8 years

XML

Leases - Maturities of Lease Liabilities (Details) - USD ($) $ in Thousands	Jun. 30, 2020	Dec. 31, 2019
Leases [Abstract]
Remainder of 2020	$ 1,212
2021	2,577
2022	1,732
2023	1,552
2024	1,552
After 2024	4,398
Total lease payments	13,023
Less: Discount	2,361
Present value of lease liabilities	10,662
Current portion of operating lease obligation	1,873	$ 1,752
Non-current portion of lease liabilities	$ 8,789	$ 9,773

XML

Debt - Net Carrying Amount of Debt (Details) - USD ($) $ in Thousands	Jun. 30, 2020	Dec. 31, 2019
Debt
Unamortized deferred finance costs related to term loan	$ (129)	$ (179)
Total	18,131	18,821
Current portion of long-term debt	2,900	2,250
Long-term debt	15,231	16,571
Xcel Term Loan
Debt
Term Loan	18,250	$ 19,000
Economic Injury Disaster Loan
Debt
Term Loan	$ 10

XML

Debt - Xcel Loan Narrative (Details)		3 Months Ended		6 Months Ended
	Feb. 11, 2019 USD ($) loan	Jun. 30, 2020 USD ($)	Jun. 30, 2019 USD ($)	Jun. 30, 2020 USD ($)	Jun. 30, 2019 USD ($)	Feb. 10, 2019 USD ($)
Debt
Loss on extinguishment of debt		$ 0	$ 0	$ 0	$ (189,000)
Interest expense		299,000	348,000	593,000	638,000
Xcel Term Loan
Debt
Face amount of loan						$ 14,500,000
Capacity available to convert to incremental term loans	$ 5,000,000
Maximum Prepayment Of Debt Amount	$ 750,000
Interest expense		$ 285,000	$ 326,000	$ 572,000	$ 586,000
Effective interest rate (as percentage)		6.60%	6.80%	6.60%	6.80%
Loan To Be Repaid As Percentage Of Excess Cash Flow Percent		50.00%
Xcel Term Loan A
Debt
Stated interest rate (as percentage)	5.10%
Xcel Term Loan B
Debt
Stated interest rate (as percentage)	6.25%
Second Amended And Restated Loan And Security Agreement
Debt
Minimum net worth required to meet loan covenant	$ 90,000,000
Second Amended And Restated Loan And Security Agreement | Xcel Term Loan
Debt
Face amount of loan	$ 22,000,000
Number of term loans | loan	2
Loss on extinguishment of debt			$ 200,000
Upfront fee for debt issuance	$ 90,000
Second Amended And Restated Loan And Security Agreement | Xcel Term Loan | Through December 31, 2020
Debt
Minimum liquid assets to meet loan covenants	3,000,000
Second Amended And Restated Loan And Security Agreement | Xcel Term Loan | Fiscal quarters ending March 31, 2021 through September 30, 2021
Debt
Minimum liquid assets to meet loan covenants	2,500,000
Second Amended And Restated Loan And Security Agreement | Xcel Term Loan | Fiscal quarter ending December 31, 2021
Debt
Minimum liquid assets to meet loan covenants	3,000,000
Second Amended And Restated Loan And Security Agreement | Xcel Term Loan | After December 31 2021
Debt
Minimum liquid assets to meet loan covenants	5,000,000
Second Amended And Restated Loan And Security Agreement | Xcel Term Loan | Twelve fiscal month period ended March 31, 2020
Debt
Minimum EBITDA to meet loan covenants	5,000,000
Second Amended And Restated Loan And Security Agreement | Xcel Term Loan | Twelve fiscal month period ending June 30, 2020
Debt
Minimum EBITDA to meet loan covenants	4,800,000
Second Amended And Restated Loan And Security Agreement | Xcel Term Loan | Twelve Month Fiscal Period Ending September 30 2020 [Member]
Debt
Minimum EBITDA to meet loan covenants	5,000,000
Second Amended And Restated Loan And Security Agreement | Xcel Term Loan | Fiscal year ending December 31, 2020
Debt
Maximum capital expenditures required to meet loan covenants	1,600,000
Second Amended And Restated Loan And Security Agreement | Xcel Term Loan | Fiscal year beginning after December 31, 2020
Debt
Maximum capital expenditures required to meet loan covenants	700,000
Second Amended And Restated Loan And Security Agreement | Additional Term Loan
Debt
Face amount of loan	7,500,000
Second Amended And Restated Loan And Security Agreement | Xcel Term Loan A
Debt
Face amount of loan	7,300,000
Second Amended And Restated Loan And Security Agreement | Xcel Term Loan B
Debt
Face amount of loan	$ 14,700,000
Revolving Credit Facility | Xcel Term Loan | Base Rate
Debt
Basis spread on variable rate	2.00%
Debt Termination Period, On Or Before Second Anniversary | Xcel Term Loan A
Debt
Termination fee percentage	1.00%
Debt Termination Period, On Or Before Second Anniversary | Xcel Term Loan B
Debt
Termination fee percentage	2.00%
Debt Termination Period, After Second Anniversary But Before Third Anniversary | Xcel Term Loan A
Debt
Termination fee percentage	0.50%
Debt Termination Period, After Second Anniversary But Before Third Anniversary | Xcel Term Loan B
Debt
Termination fee percentage	1.00%
Debt Termination Period, After Third Anniversary
Debt
Termination fee percentage	0.00%

XML

Debt - Xcel Term Loan Fixed Installments (Details) - Xcel Term Loan $ in Thousands	3 Months Ended
	Jun. 30, 2020 USD ($)
Debt
Repayment of loan as a percentage of Excess cash flow	50.00%
Minimum principal payment	$ 4,450
September 30, 2020 and December 31, 2020
Debt
Quarterly installment payments on term loans	750
March 31, 2021, June 30, 2021, September 30, 2021, and December 31, 2021
Debt
Quarterly installment payments on term loans	700
March 31, 2022, June 30, 2022, September 30, 2022, and December 31, 2022
Debt
Quarterly installment payments on term loans	1,125
March 31, 2023, June 30, 2023, September 30, 2023, and December 31, 2023
Debt
Quarterly installment payments on term loans	$ 1,250

XML

Debt - Xcel Term Loan Remaining Principal Payments (Details) - Xcel Term Loan - USD ($) $ in Thousands	Jun. 30, 2020	Dec. 31, 2019
Debt
2020	$ 1,500
2021	2,800
2022	8,950
2023	5,000
Total	$ 18,250	$ 19,000

XML

Debt - Schedule of Fixed Charge Coverage Ratios and Leverage Ratios (Details) - Second Amended And Restated Loan And Security Agreement - Xcel Term Loan	Feb. 11, 2019
December 31, 2020, March 31, 2021, June 30, 2021, September 30, 2021, and December 31, 2021
Debt
Fixed charge coverage ratio required to meet loan covenant	1.25
March 31, 2022, and thereafter
Debt
Fixed charge coverage ratio required to meet loan covenant	1.10
June 30, 2020
Debt
Leverage ratio required for loan covenant	4.25
September 30, 2020
Debt
Leverage ratio required for loan covenant	4.00
December 31, 2020
Debt
Leverage ratio required for loan covenant	3.50
March 31, 2021
Debt
Leverage ratio required for loan covenant	3.15
June 30, 2021
Debt
Leverage ratio required for loan covenant	3.00
September 30, 2021
Debt
Leverage ratio required for loan covenant	2.75
December 31, 2021
Debt
Leverage ratio required for loan covenant	2.50
March 31, 2022 and each Fiscal Quarter end thereafter
Debt
Leverage ratio required for loan covenant	1.50

XML

Debt - PPP Loan (Details) - USD ($)		3 Months Ended		6 Months Ended
	Apr. 20, 2020	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Debt Instrument [Line Items]
Grants recognized as a reduction to operating expenses		$ 1,640,000		$ 1,640,000
Interest expense		$ 299,000	$ 348,000	$ 593,000	$ 638,000
PPP Loan
Debt Instrument [Line Items]
Face amount of loan	$ 1,806,000
Stated interest rate (as percentage)	1.00%
Term of loan	2 years
Grants recognized as a reduction to operating expenses	$ 1,640,000
Interest expense	0
Accounts Payable and Accrued Liabilities | PPP Loan
Debt Instrument [Line Items]
Deferred credit	$ 166,000

XML

Debt - Economic Injury Disaster Loan (Details) - Economic Injury Disaster Loan	May 04, 2020 USD ($)
Debt Instrument [Line Items]
Face amount of loan	$ 10,000
Term of loan	30 years
Stated interest rate (as percentage)	3.75%

XML

Stockholders' Equity - 2011 Equity Incentive Plan (Details) - 2011 Equity Incentive Plan	Jun. 30, 2020 shares
Stockholders’ Equity
Number of common stock eligible for issuance	13,000,000
Shares of common stock available for issuance (in shares)	1,218,670
Shares of common stock reserved for issuance (in shares)	9,338,610

XML

Stockholders' Equity - Stock Options (Details) - USD ($)								3 Months Ended		6 Months Ended		12 Months Ended
	Apr. 15, 2020	Apr. 01, 2020	Mar. 31, 2020	Mar. 13, 2020	Feb. 28, 2020	Jan. 31, 2020	Jan. 01, 2020	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019	Dec. 31, 2019
Number of Options
Outstanding, beginning balance (in shares)							7,222,625			7,222,625
Granted (in shares)										443,500
Canceled (in shares)										0
Exercised (in shares)										0
Expired/Forfeited (in shares)										(126,000)
Outstanding, ending balance (in shares)								7,540,125		7,540,125		7,222,625
Exercisable (in shares)								2,939,625		2,939,625
Weighted Average Exercise Price
Outstanding, beginning balance (in dollars per share)							$ 3.33			$ 3.33
Granted (in dollars per share)										1.47
Canceled (in dollars per share)										0.00
Exercised (in dollars per share)										0.00
Expired/Forfeited (in dollars per share)										1.81
Outstanding, ending balance (in dollars per share)								$ 3.32		3.32		$ 3.33
Exercisable (in dollars per share)								$ 5.04		$ 5.04
Other disclosures
Outstanding Weighted Average Remaining Contractual Life (in Years)										5 years 3 months 22 days		5 years 9 months 26 days
Exercisable Weighted Average Remaining Contractual Life (in Years)										1 year 7 months 13 days
Aggregate Intrinsic Value, Outstanding								$ 0		$ 0		$ 0
Aggregate Intrinsic Value, Exercisable								0		$ 0
Board Observer
Number of Options
Granted (in shares)							5,000
Weighted Average Exercise Price
Granted (in dollars per share)							$ 4.00
Other disclosures
Vesting percentage per year							50.00%
Consultant
Number of Options
Granted (in shares)	13,500					75,000
Weighted Average Exercise Price
Granted (in dollars per share)	$ 3.00					$ 1.57
Other disclosures
Awards that vested (as a percent)										33.33%
Vesting percentage per year	33.33%
Employee
Number of Options
Granted (in shares)			50,000		50,000
Weighted Average Exercise Price
Granted (in dollars per share)			$ 0.61		$ 1.40
Other disclosures
Vesting percentage per year			33.33%
A certain key employee
Number of Options
Granted (in shares)				50,000
Weighted Average Exercise Price
Granted (in dollars per share)				$ 5.50
Non Management Directors
Number of Options
Granted (in shares)		200,000
Weighted Average Exercise Price
Granted (in dollars per share)		$ 0.50
Other disclosures
Vesting percentage per year		50.00%
Employee Stock Option
Number of Options
Granted (in shares)										443,500
Employee Stock Option
Other disclosures
Compensation expense								45,000	$ 73,000	$ 113,000	$ 316,000
Unrecognized compensation expense								$ 250,000		$ 250,000
Weighted average period of recognition										1 year 6 months
Employee Stock Option | Five year expiration
Stockholders’ Equity
Expiration period										5 years
Employee Stock Option | Seven year expiration
Stockholders’ Equity
Expiration period										7 years
Employee Stock Option | Ten year expiration
Stockholders’ Equity
Expiration period										10 years

XML

Stockholders' Equity - Non-Vested Options (Details)	6 Months Ended
	Jun. 30, 2020 $ / shares shares
Number of Options
Granted (in shares)	443,500
Employee Stock Option
Number of Options
Beginning Balance (in shares)	4,551,500
Granted (in shares)	443,500
Vested (in shares)	(279,500)
Forfeited or Canceled (in shares)	(115,000)
Ending Balance (in shares)	4,600,500
Weighted Average Grant Date Fair Value
Beginning Balance (in dollars per share) | $ / shares	$ 0.18
Granted (in dollars per share) | $ / shares	0.13
Vested (in dollars per share) | $ / shares	0.68
Forfeited or Canceled (in dollars per share) | $ / shares	0.34
Ending Balance (in dollars per share) | $ / shares	$ 0.14

XML

Stockholders' Equity - Warrants (Details) - Warrant - USD ($)	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019	Dec. 31, 2019
Number of Other than Options
Outstanding and exercisable, beginning balance (in shares)			579,815
Granted (in shares)			0
Canceled (in shares)			0
Exercised (in dollars per share)			0
Expired/Forfeited (in shares)			0
Outstanding and exercisable, ending balance (in shares)	579,815		579,815		579,815
Weighted Average Exercise Price
Outstanding, beginning balance (in dollars per share)			$ 4.63
Granted (in dollars per share)			0.00
Canceled (in dollars per share)			0.00
Exercised (in dollars per share)			0.00
Expired/Forfeited (in dollars per share)			0.00
Outstanding, ending balance (in dollars per share)	$ 4.63		$ 4.63		$ 4.63
Weighted Average Remaining Contractual Life (in Years), Outstanding and exercisable			1 year 9 months 22 days		2 years 3 months 26 days
Aggregate Intrinsic Value, Outstanding and exercisable	$ 0		$ 0		$ 0
Other disclosures
Compensation expense	$ 0	$ 0	$ 0	$ 0
Five year expiration
Stockholders’ Equity
Expiration period			5 years
Ten year expiration
Stockholders’ Equity
Expiration period			10 years

XML

Stockholders' Equity - Stock Awards (Details) - USD ($)			3 Months Ended		6 Months Ended
	May 20, 2020	Mar. 30, 2020	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Restricted Stock
Number of Other than Options
Outstanding and exercisable, beginning balance (in shares)					1,230,623
Granted (in shares)					607,428
Canceled (in shares)					0
Vested (in shares)					1,057,218
Expired/Forfeited (in shares)					0
Outstanding and exercisable, ending balance (in shares)			780,833		780,833
Weighted Average Exercise Price
Outstanding, beginning balance (in dollars per share)					$ 4.33
Granted (in dollars per share)					0.80
Canceled (in dollars per share)					0.00
Vested (in dollars per share)					2.47
Expired/Forfeited (in dollars per share)					0.00
Outstanding, ending balance (in dollars per share)			$ 4.09		$ 4.09
Other disclosures
Compensation expense			$ 10,000	$ 104,000	$ 33,000	$ 166,000
Unrecognized compensation expense			32,000		$ 32,000
Weighted average period of recognition					9 months
Restricted Stock | Senior Management
Number of Other than Options
Granted (in shares)		336,700
Restricted Stock | Employees
Number of Other than Options
Granted (in shares)	270,728
Other disclosures
Compensation expense			265,000		$ 265,000
Management Stock Bonus
Other disclosures
Compensation expense			$ 168,000		$ 320,000

XML

Earnings Per Share - Dilutive Earnings Per Share (Details) - shares	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Earnings Per Share Basic And Diluted [Line Items]
Basic (in shares)	19,132,244	18,976,394	19,001,321	18,770,378
Diluted (in shares)	19,132,244	18,977,051	19,001,321	18,771,053
Warrant
Earnings Per Share Basic And Diluted [Line Items]
Effect of exercise of Warrants (in shares)	0	657	0	675

XML

Earnings Per Share - Anti-dilutive Securities Excluded (Details) - shares	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Earnings Per Share [Abstract]
Stock options and warrants (in shares)	8,119,940	8,408,386	8,119,940	7,124,005

XML

Income Tax (Details) - USD ($)		3 Months Ended		6 Months Ended
	Mar. 27, 2020	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Effective income tax rate		(49.00%)	37.00%	5.00%	37.00%
Income tax (benefit) provision		$ 428,000	$ 1,068,000	$ (124,000)	$ 1,143,000
Effect of vesting of restricted shares of common stock on effective tax rate		(41.00%)		(16.00%)
Effect of state taxes on effective tax rate		(2.00%)	9.00%	5.00%	9.00%
Effect of permanent differences on effective tax rate		(27.00%)	6.00%	(8.00%)	6.00%
Effect of potential federal net operating loss carryback due to the CARES Act on effective tax rate		3.00%		4.00%
Operating loss carryback period	5 years
COVID19
Income tax (benefit) provision				$ (98,000)
Tax refund receivable		$ 203,000		$ 203,000

XML

Related Party Transactions (Details) - USD ($)		3 Months Ended		6 Months Ended
	Feb. 11, 2019	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Halston Heritage
Asset Purchase Agreement
Cash included in aggregate purchase price	$ 8,400,000
Common stock included in aggregate purchase price (in shares)	777,778
Issuance of common stock in connection with Halston Heritage assets acquisition	$ 1,100,000
Aggregate contingent consideration	6,000,000
Minimum deduction from net royalties	$ 1,500,000
Maximum percentage of issued/issuable of earn-out shares	4.99%
Halston Heritage | 50% of the first $10,000,000 of Excess Net Royalties
Asset Purchase Agreement
Applicable percentage	50.00%
Halston Heritage | 20% of aggregate Excess Net Royalties greater than $10,000,000 and up to $15,000,000
Asset Purchase Agreement
Applicable percentage	20.00%
Halston Heritage | 0% of aggregate Excess Net Royalties in excess of $15,000,000
Asset Purchase Agreement
Applicable percentage	0.00%
Maximum | Halston Heritage | 50% of the first $10,000,000 of Excess Net Royalties
Asset Purchase Agreement
Excess net royalties	$ 10,000,000
Maximum | Halston Heritage | 20% of aggregate Excess Net Royalties greater than $10,000,000 and up to $15,000,000
Asset Purchase Agreement
Excess net royalties	15,000,000
Minimum | Halston Heritage | 20% of aggregate Excess Net Royalties greater than $10,000,000 and up to $15,000,000
Asset Purchase Agreement
Excess net royalties	10,000,000
Minimum | Halston Heritage | 0% of aggregate Excess Net Royalties in excess of $15,000,000
Asset Purchase Agreement
Excess net royalties	$ 15,000,000
Wife Of Robert W. D’Loren
Asset Purchase Agreement
Period for which the related party has worked in company's ERP system				2 years
Compensation		$ 33,000	$ 44,000	$ 70,000	$ 83,000
House Of Halston LLC | Former Director
Asset Purchase Agreement
Ownership Percentage in HOH		25.00%		25.00%

XML

Commitments and Contingencies (Details) - Halston Heritage Trademarks - USD ($) $ in Millions	Feb. 11, 2019	Jun. 30, 2020	Dec. 31, 2019
Commitments and Contingencies
Contingent consideration	$ 6.0
Earn-out liability recorded		$ 0.9	$ 0.9

XML

Subsequent Events (Details)	Aug. 06, 2020 USD ($)
Subsequent Events
Subsequent Event [Line Items]
Consideration for release of obligations and rights to the lease at 475 Tenth Avenue	$ 887,000